d-alpha tocopherol has been researched along with Cardiovascular Diseases in 492 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (6.71) | 18.7374 |
1990's | 92 (18.70) | 18.2507 |
2000's | 237 (48.17) | 29.6817 |
2010's | 115 (23.37) | 24.3611 |
2020's | 15 (3.05) | 2.80 |
Authors | Studies |
---|---|
Barresi, E; Cosconati, S; Da Settimo, F; Di Maro, S; La Motta, C; Marinelli, L; Marini, AM; Novellino, E; Salerno, S; Sartini, S; Simorini, F; Taliani, S | 1 |
Bang, WY; Cho, H; Kim, HE; Kwon, T; Kwon, TK; Park, TJ; Sim, HJ; Yang, HS | 1 |
Albanes, D; Derkach, A; Gu, F; Hua, X; Huang, J; Liao, LM; Mondul, AM; Moore, SC; Sampson, JN; Weinstein, SJ | 1 |
Al-Okbi, SY; El-Ghlban, S; El-Qousy, SM; Moawad, HF | 1 |
Aune, D; Boffetta, P; Fadnes, LT; Giovannucci, E; Greenwood, DC; Keum, N; Norat, T; Riboli, E; Tonstad, S; Vatten, LJ | 1 |
Albanes, D; Huang, J; Männistö, S; Weinstein, SJ; Yu, K | 1 |
Bae, SR; Kawanishi, N; Miyashita, M; Nakamura, Y; Park, JH; Sakamoto, S; Suzuki, K; Takahashi, M | 1 |
Choudhury, K; Clark, J; Griffiths, HR | 1 |
Avila, PC; Colangelo, LA; Cook-Mills, JM; Gross, M; Jacobs, DR; Kumar, R; Liu, K; Marchese, ME; Sood, A | 1 |
Blomhoff, R; Ha, L; Hauge, T; Iversen, PO; Veierød, MB | 1 |
Caballero, J; Campoy, C; Castellote, AI; Garagorri, JM; Guerendiain, M; López-Belmonte, G; López-Sabater, MC; Marcos, A; Martí, A; Martín-Bautista, E; Martín-Matillas, M; Martínez, JA; Mayneris-Perxachs, J; Montes, R; Moreno, L; Wärnberg, J | 1 |
Brown, RC; Chisholm, AW; Gray, AR; Robinson, T; Tey, SL | 1 |
Belanger, C; Bubes, V; Buring, JE; Christen, WG; Gaziano, JM; Glynn, RJ; Kurth, T; MacFadyen, J; Manson, JE; Sesso, HD | 1 |
Abdalla, DS; Barreira, AL; de Mattos Grosso, D; Leite, M; Lobo, JC; Mafra, D; Santos, FR; Velarde, LG | 1 |
Kar, A; Panda, S | 1 |
Jang, Y; Kim, HJ; Kim, JY; Kim, OY; Lee, JH; Lee, KP; Lee, SH; Park, JY; Yoe, HY | 1 |
Lee, SH; Park, E; Park, YK | 1 |
Huebbe, P; Lodge, JK; Rimbach, G | 1 |
Ardigò, D; Bianchi, MA; Brighenti, F; Del Rio, D; Franzini, L; Pellegrini, N; Piatti, PM; Scazzina, F; Valtueña, S; Zavaroni, I | 1 |
Bremner, DM; Duthie, GG; Fyfe, CL; Horgan, GW; Johnstone, AM; Lobley, GE; Morrice, PC | 1 |
Prabu, SM; Renugadevi, J; Shagirtha, K | 1 |
Iso, H; Moriyama, Y; Nagao, M; Tamakoshi, A; Yamagishi, K | 1 |
Devaraj, S; Jialal, I | 5 |
Riley, SJ; Stouffer, GA | 1 |
Berendschot, TT; Bots, ML; Broekmans, WM; Castenmiller, WA; Kardinaal, AF; Klöpping-Ketelaars, IA; Tijburg, LB; van Poppel, G; Vink, AA; Weststrate, JA | 1 |
Hsu, A; Penn, MS; Sapp, SK; Topol, EJ; Vivekananthan, DP | 1 |
CHURG, J; LEHR, D; MILORA, R | 1 |
Azzi, A; Gysin, R; Kempná, P; Ricciarelli, R; Villacorta, L; Visarius, T; Zingg, JM | 1 |
Breeze, E; Fletcher, AE; Shetty, PS | 1 |
Dumas, M; Ecarnot-Laubriet, A; Goirand, F; Guilland, JC; Moreau, D; Renard, C; Rochette, L; Vergely, C | 1 |
Friedrich, MJ | 1 |
O'CONNOR, VR | 2 |
Barancoková, M; Collins, A; Dusinská, M; Horská, A; Kazimírová, A; Raslová, K; Smolková, B; Spustová, V | 1 |
Comstock, GW; Genkinger, JM; Helzlsouer, KJ; Hoffman, SC; Platz, EA | 1 |
Jialal, I; Singh, U | 1 |
Blumberg, J; Jialal, I; Lunec, J; Meydani, S; Packer, L; Violi, F; Willett, W | 1 |
Hoppe, PP; Koch, W; Kraemer, K | 1 |
Arnold, A; Arnold, JM; Bosch, J; Dagenais, GR; Lonn, E; Pogue, J; Probstfield, J; Ross, C; Sheridan, P; Sleight, P; Yusuf, S | 1 |
Buring, JE; Cook, NR; Gaziano, JM; Gordon, D; Hennekens, CH; Lee, IM; Manson, JE; Ridker, PM | 1 |
Jacobs, EJ; Thun, MJ | 1 |
Redberg, RF | 1 |
Richey, RM | 1 |
Gaby, AR | 1 |
Dangovian, MI; Hightower, KR; Jarski, RW | 1 |
Buijsse, B; de Groot, LC; Ferry, M; Feskens, EJ; Kok, FJ; Kromhout, D; Schlettwein-Gsell, D | 1 |
Ammar, H; Haidara, MA; Rateb, M; Yassin, HZ; Zorkani, MA | 1 |
Leichtle, A; Teupser, D; Thiery, J | 1 |
Albanes, D; Lawson, KA; Pietinen, P; Taylor, PR; Virtamo, J; Weinstein, SJ; Wright, ME | 1 |
Cesari, M; Il'yasova, D; Ivanova, A; Morrow, JD; Pahor, M | 1 |
Farwell, WR; Michael Gaziano, J; Norkus, EP; Sesso, HD | 1 |
Bito, Y; Minamiyama, Y; Nakahira, A; Okada, S; Shinkawa, H; Suehiro, S; Takemura, S; Tsukioka, T | 1 |
Schwenke, DC | 3 |
Ames, BN; Christen, S; Jiang, Q; Shigenaga, MK | 1 |
Alaupovic, P; Albers, JJ; Bolson, EL; Brown, BG; Chait, A; Cheung, MC; Dowdy, AA; Fisher, LD; Frohlich, J; Marino, EK; Morse, JS; Zhao, XQ | 1 |
Carnevale, R; Loffredo, L; Nocella, C; Pignatelli, P; Violi, F | 1 |
Chang, SK; Khaza'ai, H; Kutty Radhakrishnan, A; Zainal, Z | 1 |
Dobrowolska, A; Hryhorowicz, S; Krela-Kaźmierczak, I; Rychter, AM; Słomski, R | 1 |
Barry, MJ; Cabana, M; Chelmow, D; Coker, TR; Davis, EM; Donahue, KE; Doubeni, CA; Jaén, CR; Kubik, M; Li, L; Mangione, CM; Nicholson, WK; Ogedegbe, G; Pbert, L; Ruiz, JM; Stevermer, J; Wong, JB | 1 |
Tanner, M | 1 |
Álvares-da-Silva, MR; Behrens, L; Cerski, CT; de Freitas, LBR; de Souza, VEG; Filippi-Chiela, E; Leonhard, LC; Lima, GJSP; Longo, L; Luchese, E; Pereira, MHM; Pinzon, CE; Uribe-Cruz, C; Zanettini, G | 1 |
Aoki, Y; Fukui, K; Kato, Y | 1 |
Papagiouvannis, G; Rekka, EA; Theodosis-Nobelos, P | 1 |
Levy, AP; Somer, S | 1 |
Hall, B; Sadowska-Krępa, E; Stanula, A; Stolecka-Warzecha, A; Żebrowska, A | 1 |
Classen, HG; Eckert, GP; Egert, S; Frank, J; Golombek, J; Kisters, K; Lorkowski, S; Obeid, R; Pettersen, JA; Podszun, MC; Stirban, OA; Venturelli, S; Wallert, M | 1 |
Chong, CYE; Lee, CJ; Poon, DTS; Pui, LP; Tan, CH; Tan, SN | 1 |
Berinstein, EM; Hochberg, I; Levy, AP; Milman, U; Shapira, C | 1 |
Adamopoulos, K; Apostolidou, C; Iliadis, S; Kourtidou-Papadeli, C; Lymperaki, E; Papapreponis, P | 1 |
Blumberg, JB; Chen, CO; Jung, H; Kwak, HK | 1 |
Ballantyne, CM; Barter, PJ; Bochem, AE; Boekholdt, SM; Hoogeveen, RC; Hovingh, GK; Kastelein, JJP; Khaw, KT; Mora, S; Ridker, PM; Sun, W; Tall, AR; van Capelleveen, JC; Wareham, NJ; Zwinderman, AH | 1 |
Hajri, T | 1 |
Bo, L; Du, X; Jiang, R; Jiang, S; Liu, J; Song, W; Zeng, X; Zhao, J | 1 |
Cook, NR; Mora, S; Ridker, PM | 1 |
Alcalá-Díaz, JF; Corina, A; Delgado-Lista, J; Jiménez-Lucena, R; López-Miranda, J; López-Moreno, J; Ordovás, JM; Pérez-Martínez, P; Quintana-Navarro, G; Rangel-Zúñiga, OA; Tinahones, F; Yubero-Serrano, EM | 1 |
Balla, J; Harangi, M; Juhász, L; Lőrincz, H; Paragh, G; Seres, I; Szentpéteri, A; Varga, VE | 1 |
Baral, D; Baral, N; Khan, SA; Khanal, S; Lamsal, M; Shrestha, S | 1 |
Berco, M; Bhavnani, BR; Cecutti, A; Gerulath, A; Woolever, AC | 1 |
Jenkins, N; Li, KJ; Luckasen, G; Rao, S; Ryan, EP | 1 |
Chan, RSM; Cheung, BMY; Cheung, CYY; Fong, CHY; Janus, E; Lam, KSL; Lam, TH; Lee, CH; Wan, HYL; Woo, J; Woo, YC | 1 |
Jayedi, A; Parohan, M; Rashidy-Pour, A; Shab-Bidar, S; Zargar, MS | 1 |
Demirel, T; Ozer, NK; Sozen, E | 1 |
Ahmad, SP; Akbarzadeh, M; Babajafari, S; Farajbakhsh, A; Ferns, GA; Mazidi, M; Mazloomi, SM; Ofori-Asenso, R; Rezaie, P | 1 |
Hosseni, B; Kakavandi, N; Khosravi, M; Mohammadi, A; Najafi, M; Naseri, F; Piran, S; Resaee, S; Sarmasti, S; Shabani, M; Soltanmohammadi, E | 1 |
Gargari, BP; Izadi, A; Shirazi, S; Taghizadeh, S | 1 |
Li, J; Ye, Y; Yuan, Z | 1 |
Goldenstein, H; Levy, AP; Levy, NS; Lipener, YT | 1 |
Levy, AP; Levy, NS; Vardi, M | 1 |
Moser, U | 1 |
Chun, OK; Song, WO; Wang, Y | 1 |
Evans, RD; Giussani, DA; Herrera, EA; Niu, Y | 1 |
Bennet, L | 1 |
Bjelakovic, G; Gluud, C; Nikolova, D | 1 |
Moyer, VA | 1 |
Meah, VL; Stembridge, M; Stöhr, EJ | 1 |
Adolph, M; Biesalski, HK; Duquesne, M; Nohr, D; Rodemeister, S; Unertl, K | 1 |
Arvat, E; Berardelli, R; D'Angelo, V; Fussotto, B; Ghigo, E; Giordano, R; Karamouzis, I; Maccario, M; Settanni, F; Zichi, C | 1 |
Buring, JE; Chasman, DI; Davis, RB; Hall, KT; Kaptchuk, TJ; Kirsch, I; Loscalzo, J; Mittleman, MA; Nelson, CP; Ridker, PM; Samani, NJ | 1 |
Jiang, S; Li, F; Li, H; Pan, Z; Qiu, Y; Song, Y | 1 |
Ochi, H; Takeda, S | 1 |
Chalasani, N; Corey, KE; Cummings, OW; Vuppalanchi, R; Wilson, LA | 1 |
Gallo, M; Langella, C; Marino, M; Naviglio, D | 1 |
Bobak, M; Grosso, G; Kubinova, R; Malyutina, S; Micek, A; Nikitin, Y; Pająk, A; Peasey, A; Pikhart, H; Stefler, D; Stepaniak, U; Topor-Madry, R | 1 |
Joris, PJ; Mensink, RP | 1 |
Anstee, QM; Day, CP; Hardy, T | 1 |
Buring, JE; Christen, WG; Cook, NR; Ridker, PM | 1 |
Khadem Ansari, MH; Nemati, S; Norouzi, L; Shirpoor, A | 1 |
Choi, BY; Chun, BY; Hong, KW; Hwang, JY; Jung, S; Kim, MK; Lee, YH; Park, CY; Shin, DH; Shin, MH | 1 |
Kamisah, Y; Kamsiah, J; Siti, HN | 1 |
Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM | 1 |
Bessell, E; Jose, MD; McKercher, C | 1 |
Kumar, S; Manivannan, J; Mishra, SK; Prahalathan, P; Raja, B; Saravanakumar, M; Silambarasan, T | 1 |
Carter, AM; Dunn, EJ; Lines, SW; Richardson, VR; Thomas, B; Wright, MJ | 1 |
Blankenberg, S; Chapman, MJ; Landmesser, U | 1 |
Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM; Srivastava, PK | 1 |
Charlton, MR; Dick, TB; Pham, T | 1 |
Azzi, A; Birringer, M; Cook-Mills, JM; Cruciani, G; Eggersdorfer, M; Frank, J; Galli, F; Lorkowski, S; Özer, NK | 1 |
Hosseini, B; Saedisomeolia, A; Skilton, MR | 1 |
Bo, L; Du, X; He, Q; Jiang, S; Liu, J; Song, W; Xie, Y; Ye, X; Zeng, X; Zhao, J | 1 |
Gao, J; Li, HL; Shu, XO; Sun, JW; Xiang, YB; Zhang, W; Zhao, LG; Zheng, W | 1 |
Aurelio, A; Bianchini, E; Carone, S; Ciccone, MM; Clemente, O; Corsonello, A; Cortese, F; D Arcangelo, AP; Faita, F; Gelsumino, T; Gemignani, V; Greco, L; Guadalupi, G; Incalzi, RA; Minotti, GC; Naio, R; Palumbo, SD; Primerano, R; Vigotti, M | 1 |
Choo, YM; Loganathan, R; Radhakrishnan, AK; Subramaniam, KM; Teng, KT | 1 |
Abdulaal, WH; Ahmad, W; Ashraf, MA; Asif, M; Choudhry, H; Iqbal, A; Iram, S; Jamal, MS; Kamran, K; Khan, AR; Khan, SA; Khan, SU; Malik, A; Mustafa, MZ; Qaisrani, MM; Qazi, MH; Rasool, M; Raza, A; Waquar, S; Zaheer, A; Zamzami, MA | 1 |
Bazzano, LA; Riccioni, G | 1 |
Kamel, MA; Shehata, M | 1 |
Buring, JE; Kurth, T; Schürks, M; Zee, RY | 1 |
Burnett, JR; Clarke, MW; Croft, KD | 1 |
Bell, SJ; Grochoski, GT | 1 |
Buring, JE; Gaziano, JM; Norkus, EP; Sesso, HD; Wang, L | 1 |
Buring, JE; Cook, NR; Manson, JE; Pradhan, AD; Ridker, PM | 1 |
SHUTE, EV; VOGELSANG, AB | 1 |
Block, G; Crawford, PB; Dalvi, TB; Fung, EB; Harmatz, P; Holland, N; Hudes, M; Jensen, CD; Norkus, EP; Schumacher, L | 1 |
Abbatecola, AM; Barbieri, M; Cioffi, M; Forsey, R; Grella, R; Molinari, A; Paolisso, G; Powell, J; Rizzo, MR; Vietri, MT | 1 |
Lichtenstein, AH | 2 |
Albert, C; Buring, JE; Cook, NR; Gaziano, JM; Lin, J; Manson, JE; Van Denburgh, M; Zaharris, E | 1 |
D'Agostino, RB; Dietrich, M; Jacques, PF; Kaur, G; Keyes, MJ; Lanier, K; Pencina, MJ; Vasan, RS; Wolf, PA | 1 |
Gratsianskiĭ, NA | 1 |
Frei, B; Roberts, LJ; Traber, MG | 1 |
Dotan, Y; Leshno, M; Lichtenberg, D; Pinchuk, I | 1 |
George, TW; Gordon, MH; Lovegrove, JA; Niwat, C; Waroonphan, S | 1 |
Al-Merri, K; Al-Nemer, K; Dagenais, G; Healey, J; Lonn, E; Mann, JF; Mathew, J; Salehian, O; Sumner, G; Yi, Q | 1 |
Evans, JM | 1 |
Cangemi, R; Violi, F | 2 |
Aryaeian, N; Chamari, M; Djalali, M; Djazayeri, A; Eshragian, MR; Fatehi, F; Naderi, N; Sarrafnejad, A; Shahram, F; Zarei, M | 1 |
Díaz, N; Meertens, L; Naddaf, G; Rodríguez, A; Ruido, T; Solano, L | 1 |
Buring, JE; Mora, S; Ridker, PM; Rifai, N | 1 |
Albert, CM; Buring, JE; Cook, NR; Grodstein, F; Kang, JH; Manson, JE | 1 |
Blum, S; Levy, AP; Levy, Y | 1 |
Albert, CM; Cook, NR; Manson, JE; Song, Y; Van Denburgh, M | 2 |
Kristal, AR; Peters, U; Pocobelli, G; White, E | 1 |
Barros, CR; Catania, AS; Ferreira, SR | 1 |
Chatzidimitriou, D; Kirmizis, D | 1 |
Chang, WH; Liu, JF | 1 |
Anderson, JW; Arnoldi, A; Galli, C; Sirtori, CR; Sirtori, E | 1 |
Adler, A; Camm, EJ; Giussani, DA; Hansell, JA; Richter, HG | 1 |
Gross, HB; Kalgaonkar, S; Keen, CL; Yokoyama, W | 1 |
Derks, JB; Giussani, DA; Herrera, EA; Verkerk, MM | 1 |
Blum, S; Levy, AP; Levy, NS; Miller-Lotan, R; Vardi, M | 1 |
Ait-Ameur, L; Alt, N; Birlouez-Aragon, I; Galinier, A; Lacoste, F; Lecerf, JM; Niamba, CN; Saavedra, G; Somoza, V; Tessier, FJ | 1 |
Boeing, H; Cordero, Z; Drogan, D; Weikert, C | 1 |
Evans, A; Gey, KF; Gilchrist, SE; McKinley, MC; O'Doherty, MG; Skidmore, PM; Woodside, JV; Yarnell, JW; Young, IS | 1 |
Asleh, R; Blum, S; Brown, JB; Levy, AP; Levy, NS; Miller-Lotan, R; Milman, U; Russell, A; Shapira, C; Vardi, M | 1 |
Colombo, ML | 1 |
Davison, A; Faloon, W; Firshein, R; Gleyzer, M; Gordon-Cohen, B; Hirsh, SP; Joyal, SV; Juhl, JH; Kulick, A; Ostrow, GL | 1 |
Shen, L | 1 |
Armstrong, MJ; Houlihan, DD; Rowe, IA | 1 |
Bautista-Ortega, J; Ruiz-Feria, CA | 1 |
Buring, JE; Klevak, A; Liu, S; Manson, JE; Song, Y | 1 |
Farbstein, D; Kozak-Blickstein, A; Levy, AP | 1 |
Breilmann, J; Brunner, C; Neuhäuser-Berthold, M; Pons-Kühnemann, J; Richter, M | 1 |
Chong-Han, K | 1 |
Dikshit, M; Hashemi, M; Karajibani, M; Montazerifar, F | 1 |
Calò, LA | 1 |
Martínez-González, MA; Núñez-Córdoba, JM | 1 |
Chourdakis, M; Kouvelas, D; Papazisis, G; Pourzitaki, C; Toulis, KA; Tzellos, T | 1 |
Turan, B; Vassort, G | 1 |
Abramson, J; Garelnabi, M; Parthasarathy, S; Santanam, N; Veledar, E; Weintraub, W; White-Welkley, J | 1 |
Chan, HM; De Souza, A; Hidiroglou, N; Jin, X; Kapal, K; Lau, A; Lok, E; Mehta, R; Ross, N; Sarafin, K; Taylor, M | 1 |
Angelucci, CB; Giacominelli-Stuffler, R; Maccarrone, M; Manca-di-Villahermosa, S; Taccone-Gallucci, M | 1 |
Debreceni, B; Debreceni, L | 1 |
Coombes, JS; Fassett, RG | 1 |
Chung, M; Lau, J; Lee, J; Lichtenstein, AH; Moorthy, D; Trikalinos, TA; Yu, WW | 1 |
Belarbi, M; Benmansour, N; Chemat, F; Khaldi, D; Nani, A; Sari, N; Sour, S; Visioli, F | 1 |
Azzini, E; Ciarapica, D; Durazzo, A; Foddai, MS; Fumagalli, A; Intorre, F; Maiani, G; Mauro, B; Palomba, L; Polito, A; Raguzzini, A; Venneria, E; Zaccaria, M | 1 |
Borneo, R; León, AE | 1 |
Ben Abdallah, T; Boubaker, K; Feki, M; Fellah, H; Hammami, B; Kaabachi, N; Lacour, B; Taieb, SH | 1 |
Alonso, A; Bertoni, AG; de Oliveira Otto, MC; Delclos, GL; Jacobs, DR; Jiang, R; Lee, DH; Lima, JA; Nettleton, JA; Symanski, E | 1 |
Cano, N; Chardigny, JM; Combe, N; Gladine, C; Huertas, A; Pereira, B; Rossignol-Castera, A; Salvati, S; Vaysse, C | 1 |
D'Orazio, N; Franceschelli, S; Pesce, M; Riccioni, G; Salvatore, C; Speranza, L | 1 |
Blum, S; Levy, AP; Vardi, M | 1 |
Akol'zina, SE; Baturin, AK; Beketova, NA; Kodentsova, VM; Pereverzeva, OG; Pogozheva, AV; Vrzhesinskaia, OA | 1 |
Adámkova, V; Hubacek, JA; Hubalkova, M; Lanska, V | 1 |
Boudouris, G; Evangelou, AM; Karkabounas, SCh; Ragos, V; Simos, YV; Verginadis, II; Zouridakis, A | 1 |
Carrión, JM; Guadarrama, A; Larrarte, E; Moro, C; Sanz-Buenhombre, M; Villanueva, S; Yubero, N | 1 |
Meydani, M | 4 |
Spector, R; Vesell, ES | 1 |
Márquez, M; Rincón, M; Sútil-Naranjo, R; Yépez, CE | 1 |
Bosch, J; Dagenais, G; Gerstein, HC; Hoogwerf, B; Lonn, E; Mann, JF; Pogue, J; Yi, Q; Yusuf, S; Zinman, B | 1 |
DeMichele, SJ; Edens, NK; Mustad, VA; Ruey, PP; Smith, CA | 1 |
Oliveira, L; Pereira Miguel, JM; Pereirinha, A; Reis, MF | 1 |
Yusoff, K | 1 |
Marchioli, R | 3 |
Deanfield, JE; Kattenhorn, M; Leeson, CP; Lucas, A; Mann, A; Muller, DP | 1 |
Catignani, GL; Lazarus, S; Willcox, JK | 1 |
Armitage, J; Clarke, R | 1 |
Alul, RH; Campione, AL; Longo, J; Lynch, SM; Marcotte, AL; Moore, MK; Wood, M | 1 |
Brown, DJ; Goodman, J | 1 |
Baró, L; Boza, JJ; Fonollá, J; Jiménez, J; López-Huertas, E; Lucena, A; Martínez-Férez, A; Peña, JL | 1 |
Bassuk, SS; Manson, JE; Stampfer, MJ | 1 |
Blazicek, P; Ginter, E; Hladikova, V; Klvanova, J; Krajcovicova-Kudlackova, M; Spustova, V; Ursinyova, M | 1 |
Buring, JE; Dana, MR; Schaumberg, DA; Sullivan, DA | 1 |
FLEISCHHACKER, H | 1 |
BERRYMAN, GH; BOCKMAN, AA; MELTZER, LE | 1 |
Canistro, D; Chieco, P; Paolini, M; Sapone, A; Valgimigli, L | 1 |
RUECKER, G; SZIRMAI, E | 1 |
Roychoudhury, P; Schwartz, K | 1 |
Bolton-Smith, C; Malik, NS; Mishra, GD; Paul, AA; Wadsworth, ME | 1 |
Avanzini, F; Nicolucci, A; Pellegrini, F; Roncaglioni, MC; Sacco, M; Tognoni, G | 1 |
Antoniades, C; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
De Luca, C; Deeva, I; Ibragimova, G; Korkina, L; Luci, A; Shakula, A | 1 |
Chamiec, T | 1 |
MANTERO, O | 1 |
Spirichev, VB | 1 |
MATIS, P; REIFFERSCHEID, M | 1 |
Hardy, ML; Morton, S; Shekelle, P | 1 |
Awad, AB; Horvath, PJ; Leddy, JJ; Mason, M; Meksawan, K; Pendergast, DR | 1 |
Coulter, I; Hardy, M; J Suttorp, M; Jungvig, LK; Morton, SC; Newberry, SJ; Shekelle, PG; Spar, M; Tu, W; Udani, J | 1 |
Bosch, J; Dagenais, GR; Gerstein, HC; Hoogwerf, BJ; Lonn, EM; Mann, JF; Pogue, J; Yi, Q; Yusuf, S | 1 |
Atilgan, R; Aydilek, N; Naziroğlu, M; Ozcan, Z; Simşek, H; Simşek, M | 1 |
Levy, AP | 1 |
Baró, L; Boza, JJ; Carrero, JJ; Castillo, R; Fonollá, J; González-Santiago, M; Jiménez, J; López-Huertas, E; Martínez-Férez, A | 1 |
Cozma, LS | 1 |
Alexander, J; Haugen, M; Meltzer, HM; Pedersen, JI | 1 |
Eidelman, RS; Hebert, PR; Hennekens, CH; Hollar, D; Lamas, GA | 1 |
Amouroux, P; Cardinault, N; Gueux, E; Jaffrelo, L; Mazur, A; Nicolle, C; Rémésy, C; Rock, E | 1 |
Amouroux, P; Gueux, E; Jaffrelo, L; Lab, C; Mazur, A; Nicolle, C; Rémésy, C; Rock, E | 1 |
Bilo, HJ; Diepeveen, SH; Dikkeschei, BL; Kolsters, G; Offerman, JJ; Stalenhoef, AF; van der Palen, J; van Tits, LJ; Verhoeven, GH | 1 |
BUTTURINI, U | 2 |
SCHMIDT, L | 1 |
DAVID, P; FOURCAND, J | 1 |
Gerstein, HC; Levy, AP; Lonn, E; McQueen, M; Miller-Lotan, R; Pogue, J; Ratner, R | 1 |
Hirasaka, N; Liang, XM; Mune, M | 1 |
Borowy-Borowski, H; Docherty, J; Sikorska, M; Sodja, C; Walker, PR | 1 |
Landmark, K; Reikvam, A | 1 |
Trumbo, PR | 1 |
Dagenais, GR; Lonn, E; Ostergren, J; Sleight, P; Yi, Q; Yusuf, S | 1 |
Carpentier, YA; Hacquebard, M | 1 |
Jin, M | 1 |
Gaziano, JM | 1 |
Cangemi, R; Pignatelli, P; Sabatino, G; Violi, F | 1 |
Azzi, A; Kraemer, K; Niki, E; Ozer, N; Packer, L; Sies, H; Vatassery, G; Violi, F | 1 |
Brown, BG; Crowley, J | 1 |
Biro, A; Boaz, M; Friedman, V; Gafter, U; Gvirtz, G; Himmelfarb, J; Iuliano, L; Matas, Z; McMonagle, E; Micheletta, F; Natoli, S; Sabo, G; Smetana, S; Weinstein, T | 1 |
Ahmed, WH; Al-Ama, N; Alissa, EM; Bahjri, SM; Ferns, GA; Starkey, B | 1 |
Erdmann, E; Hoppe, UC | 1 |
Guallar, E; Hanley, DF; Miller, ER | 1 |
Dagenais, GR; Gerstein, HC; Lonn, E; Mann, JF; McQueen, M; Pogue, J; Yusuf, S | 1 |
Townsend, DM; Tucker, JM | 1 |
Pham, DQ; Plakogiannis, R | 1 |
Brandt, D | 1 |
Punnam, SR | 1 |
Allan, GM; Payne, W | 1 |
Antoniades, C; Stefanadis, C; Tousoulis, D | 1 |
Demigne, C; Mazur, A; Narcy, A; Rémésy, C; Robert, L; Rock, E | 1 |
Bakker, SJ; de Jong, PE; de Vries, AP; Gans, RO; Graaff, R; Hartog, JW; Smit, AJ; van der Heide, JJ; van Son, WJ; Wolffenbuttel, BH | 1 |
Rimm, E; Stampfer, M; Willett, W | 1 |
Eckart, RE; Krasuski, RA; Michaelis, K | 1 |
Matkovics, A | 1 |
Ueda, S; Yasunari, K | 1 |
Bartunkova, J; Dusilova-Sulkova, S; Hodkova, M; Kalousova, M; Malbohan, IM; Mikova, D; Soukupova, J; Zima, T | 1 |
Chojnacki, J; Grzegorczyk, K; Kedziora, J; Rutkowski, M | 1 |
Buring, JE | 1 |
Moyad, MA; Robinson, LE | 1 |
Ben Abdallah, T; Ben Maiz, H; Feki, M; Fellah, H; Ghorbel, H; Hedhili, A; Kaabachi, N; Lacour, B; Massy, Z; Mebazaa, A; Souissi, M | 1 |
Bucciarelli, T; Corradi, F; D'Orazio, N; Di Ilio, C; Mancini, B; Mattei, PA; Riccioni, G | 1 |
Dusting, GJ; Triggle, C | 1 |
Hagen, TM; Visioli, F | 1 |
Ajuluchukwu, JN; Fasanmade, OA; Mabayoje, M; Mbakwem, AC; Ojini, FI; Oke, DA; Okubadejo, NU; Okwudiafor, RN | 1 |
Alfthan, G; Aro, A; Hörkkö, S; Kesäniemi, YA; Silaste, ML | 1 |
Bernhard, D; Wang, XL | 1 |
Fortepiani, LA; Iliescu, R; Reckelhoff, JF; Sartori-Valinotti, JC; Yanes, LL | 1 |
Buring, JE; Ding, EL; Liu, S; Manson, JE; Rifai, N; Song, Y | 1 |
Mahaney, MC; Rainwater, DL; VandeBerg, JL; Wang, XL | 1 |
Jelinek, HF; Kerr, PG; Nwose, EU; Richards, RS | 1 |
Blum, S; Levy, AP | 1 |
Firestone, RA | 1 |
DONEGAN, CK; MESSER, AL | 1 |
SHUTE, EV; SHUTE, WE; VOGELSANG, A | 1 |
Bennett, L; Blum, S; Keidar, S; Khemlin, A; Kostenko, M; Landau, M; Levy, AP; Levy, Y; Miller-Lotan, R; Milman, U; Radan, A; Shapira, C | 1 |
Moats, C; Rimm, EB | 1 |
Castilla, P; Cerrato, F; Dávalos, A; Fernández-Lucas, M; Lasunción, MA; Merino, JL; Ortuño, J; Sánchez-Martín, CC; Teruel, JL | 1 |
Ovesen, L | 1 |
Crary, EJ; McCarty, MF | 1 |
Bieri, JG; Corash, L; Hubbard, VS | 1 |
Hyvönen, L; Koivistoinen, P | 1 |
Newmark, SR | 1 |
Robinson, MF; Thomson, CD | 1 |
Horwitt, MK | 1 |
Joun, NS; Nitta, RT; Porta, EA | 1 |
Farkouh, M; Flather, M; Jha, P; Lonn, E; Yusuf, S | 1 |
Chalmers, TC | 1 |
Buring, JE; Gaziano, JM; Hennekens, CH; Manson, JE | 1 |
Salonen, JT; Ylä-Herttuala, S | 1 |
Alho, H | 1 |
DeMarco, J; Sinatra, ST | 1 |
Machlin, LJ | 1 |
Tonstad, S | 1 |
Kleijnen, J | 1 |
Burton, GW | 1 |
Barber, DA; Harris, SR | 1 |
Ballmer, PE; Gey, KF; Stähelin, HB | 1 |
Buring, JE; Hennekens, CH; Peto, R | 1 |
Buring, JE; Hennekens, CH | 2 |
Smigel, K | 1 |
Diplock, AT | 3 |
Bond, BR; Fox, PR; Hayes, KC; Moise, NS; Sisson, DD; Trautwein, EA | 1 |
Buring, JE; Cook, NR; Gaziano, JM; Hennekens, CH; Manson, JE; Ridker, PM; Spelsberg, A; Willett, WC | 1 |
Abbey, M | 1 |
Greenberg, ER; Sporn, MB | 1 |
Jain, SK; Jaramillo, JJ; Little, RL; McVie, R; Meachum, ZD; Palmer, M; Smith, T | 1 |
Gaziano, JM; Hennekens, CH | 1 |
Barbas, C; Bonet, B; Bonet, MV; Castro, M; Fraile, MV; Herrera, E; Viana, M | 1 |
Boreham, CA; Duly, EB; Evans, AE; Kennedy, DG; Macauley, D; McCrum, E; Sharpe, P; Stott, G; Sweeney, K; Trinick, TR | 1 |
Kuritzky, L | 1 |
Scott, RS | 1 |
Durlach, A; Durlach, J; Durlach, V | 1 |
Kaugars, GE; Lovas, JG; Silverman, S | 1 |
Bosch, J; Gerstein, HC; Pogue, J; Taylor, DW; Yusuf, S; Zinman, B | 1 |
Loughrey, CM; McEneny, J; McNamee, PT; Trimble, ER; Young, IS | 1 |
Charleux, JL | 1 |
Bruckner, G | 1 |
Daniel, TD; Houston, DK; Johnson, MA; Poon, LW | 1 |
Appel, LJ; Levander, OA; Levine, DM; Miller, ER | 1 |
Cockcroft, J; Gazis, A; Page, S | 1 |
Bendich, A; Machlin, LJ; Weber, P | 1 |
Kajanachumpol, S; Komindr, S; Mahaisiriyodom, A | 1 |
Amadio, E; Battino, M; Littarru, GP; Oradei, A | 1 |
Meisler, JG; Meydani, M | 1 |
Arnaud, J; Coudray, C; Favier, A; Roussel, AM | 1 |
Sies, H; Stahl, W | 1 |
Solan, SM | 1 |
Lonn, EM; Yusuf, S | 2 |
Alexander, RW; Griendling, KK | 1 |
Badiou, S; Bosc, JY; Canaud, B; Castel, J; Cristol, JP; Delage, M; Descomps, B; Maggi, MF; Michel, F; Vernet, MH | 1 |
Alessandrini, P; Bon, GB; Bucciarelli, T; Ciabattoni, G; Cipollone, F; Costantini, F; Davi, G; Mezzetti, A; Minotti, G; Patrono, C | 1 |
Arnaud, J; Coudray, C; Favier, A; Mainard, F; Roussel, AM | 1 |
Grobbee, DE; Kardinaal, AF; Princen, HM; van de Vijver, LP; van Poppel, G | 1 |
Hennekens, CH | 1 |
Alperovitch, A; Berr, C; Bonithon-Kopp, C; Coudray, C; Mainard, F; Roussel, AM | 1 |
Opie, LH | 2 |
Gey, KF | 1 |
Parthasarathy, S; Santanam, N; Shern-Brewer, R; Wetzstein, C; White-Welkley, J | 1 |
Cham, BE; Colquhoun, DM; Smith, JL | 1 |
Lengfelder, W | 1 |
Arciniegas, EL; Avila, AV; Carías, D; Cioccia, AM; Hevia, P; Mella, C | 1 |
Galan, P; Hercberg, S; Preziosi, P | 1 |
Kelly, FJ | 1 |
Dangler, C; Harpster, NK; Li, X; Marini, RP | 1 |
Titus, K | 1 |
Vogel, R | 1 |
De Lucia, D; De Rosa, N; Farzati, B; Giugliano, D; Ingrosso, D; Marfella, R; Nappo, F; Perna, AF | 1 |
Bergholm, R; Lahdenperä, S; Liu, ML; Mäkimattila, S; Mäntysaari, M; Schlenzka, A; Summanen, P; Syvänne, M; Taskinen, MR; Vakkilainen, J; Yki-Järvinen, H | 1 |
Faure, H; Fayol, V; Galabert, C; Grolier, P; Moël, GL; Nabet, F; Stephens, J | 1 |
Navino, C; Tetta, C; Verzetti, G; Wratten, ML | 1 |
Morrissey, PA; Sheehy, PJ | 1 |
Bellomo, G | 1 |
Katan, MB; Zock, PL | 1 |
Adeli, K; Chao, JT; Gapor, A; Theriault, A; Wang, Q | 1 |
Mottram, P; Nestel, P; Shige, H | 1 |
Blum, A; Cannon, RO; Csako, G; Hathaway, L; Koh, KK; Mincemoyer, R; Panza, JA; Waclawiw, MA | 1 |
Steiner, M | 1 |
SoRelle, R | 1 |
Lenhart, SE; Nappi, JM | 1 |
Kazumi, T; Yoshino, G | 1 |
Bosch, J; Dagenais, G; Pogue, J; Sleight, P; Yusuf, S | 1 |
Pryor, WA | 1 |
Schattner, A | 1 |
Kendler, BS | 1 |
Christen, WG; Gaziano, JM; Hennekens, CH | 1 |
Cooke, T; Doyle, MC; Feely, J; Wen, Y | 1 |
Mann, JF | 1 |
Miller, JL | 1 |
Scheen, AJ | 3 |
Flynn, T; Stevermer, JJ | 1 |
Hoogwerf, BJ; Young, JB | 1 |
Halliwell, B | 1 |
Lahoz Rallo, C; Mostaza Prieto, JM; Peña Valverde, R | 1 |
Jialal, I; Traber, MG | 1 |
Dagenais, GR; Marchioli, R; Tognoni, G; Yusuf, S | 1 |
Bagchi, D; Bagchi, M; Das, DK; Joshi, SS; Kuszynski, CA; Pruess, HG; Ray, SD; Stohs, SJ | 1 |
Chevet, D; Clermont, G; Lahet, J; Lecour, S; Rifle, G; Rochette, L; Siohan, P; Vergely, C | 1 |
Adams, A; McBride, PE; Underbakke, G | 1 |
Bunout, D | 1 |
Boaz, M; Brunner, D; Fainaru, M; Gafter, U; Green, MS; Iaina, A; Knecht, A; Matas, Z; Smetana, S; Weinstein, T; Weissgarten, Y | 1 |
Steinberg, D | 1 |
Kritharides, L; Teede, HJ | 1 |
Freedman, JE; Keaney, JF | 1 |
Hayek, MG; Meydani, S; Wu, D | 1 |
Yusuf, S | 1 |
Caan, BJ; Chen, C; Kristal, AR; Mares-Perlman, JA; Masaki, KH; Shikany, JM; White, E; Wilson, AC | 1 |
Devaraj, S; Jialal, I; Traber, M | 1 |
Madsen, S; Reikvam, A | 1 |
Maxwell, SR | 1 |
de Gaetano, G | 1 |
Schoonover, LL | 1 |
Ambrosi, P; Andréjak, M; Gayet, JL | 1 |
Dutta-Roy, AK | 1 |
Boaz, M; Fainauru, M; Green, M; Smetana, S | 1 |
Brown, AA; Hu, FB | 1 |
Eichholzer, M; Gutzwiller, F; Lüthy, J; Stähelin, HB | 1 |
Monge-Rojas, R | 1 |
de Graaf, J; de Waart, F; Demacker, PN; Hak-Lemmers, HL; Stalenhoef, AF; van Heijst, P; van Tits, LJ | 1 |
Bonfigli, AR; Compagnucci, P; Manfrini, S; Marra, M; Pieri, C; Ricciotti, R; Sirolla, C; Testa, I; Testa, R | 1 |
Patrick, L; Uzick, M | 1 |
Conti, AA; Gensini, GF | 1 |
Luliano, L; Micheletta, F; Violi, F | 1 |
Hooper, L; Ness, AR; Smith, GD | 1 |
Cabanne, JF; Chevet, D; Clermont, G; Guilland, JC; Lecour, S; Motte, G; Rochette, L | 1 |
De Caterina, R | 1 |
Chisholm, A; Mann, JI; McGavin, JK; Skeaff, CM | 1 |
Heinecke, JW | 1 |
Evans , P; Halliwell, B | 1 |
Hrynczuk, JR | 1 |
Fogarty, A; Gazis, A | 1 |
Kendall, MJ; Nuttall, SL; Townend, JN; Wheeler, DC | 1 |
Fryer, MJ | 1 |
Keaney, JF; Münzel, T | 1 |
McDonald, RB; Ruhe, RC | 1 |
Schoene, NW | 1 |
Iuliano, L; Micheletta, F; Violi, F | 1 |
Andreeva-Gateva, P | 1 |
Harrison, DG; Landmesser, U | 1 |
Nordt, T | 1 |
Levantesi, G; Marchioli, R; Schweiger, C; Tavazzi, L; Valagussa, F | 1 |
Gazzaniga, PP; Pignatelli, P; Pulcinelli, FM; Violi, F | 1 |
Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S | 1 |
Albertini, A; Archetti, S; Benedini, S; Bufano, G; Di Lorenzo, D; Gazzotti, RM; Gerardi, GM; Sugherini, L; Tira, P; Usberti, M; Valentini, M | 1 |
Buring, JE; Gaziano, JM; Hennekens, CH; Manson, JE; Muntwyler, J | 1 |
Asatryan, L; Hwang, J; Sevanian, A; Tetta, C; Wratten, ML; Ziouzenkova, O | 1 |
Kibata, M | 1 |
Chen, JS; Chen, LH; Hsu, SJ; Huang, C | 1 |
Domagala, TB; Musial, J; Szczeklik, A | 1 |
Conri, C; Garnier, N; Llabador, Y; Moretto, P; Sergeant, C; Simonoff, G; Simonoff, M | 1 |
Eichholzer, M; Gey, KF; Stähelin, HB | 1 |
Gunby, P | 1 |
Hamazaki, T; Kashiwabara, H; Oomori, K; Urakaze, M; Yano, S; Yokoyama, T | 1 |
Burghardt, B; Janero, DR | 1 |
de Bruijn, AM; de Bruin, M; Hermus, RJ; Hofman, A; Kok, FJ; Valkenburg, HA; van Laar, A; Vermeeren, R | 1 |
Cheraskin, E; Hicks, BS; Ringsdorf, WM | 1 |
Cheraskin, E; Ringsdorf, WM | 1 |
Vogelsang, A | 1 |
Davies, T; Kelleher, J; Losowsky, MS | 1 |
Last, G | 1 |
169 review(s) available for d-alpha tocopherol and Cardiovascular Diseases
Article | Year |
---|---|
Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Cause of Death; Diet; Feeding Behavior; Humans; Neoplasms; Nutritional Status; Vitamin E | 2018 |
Implications of apolipoprotein E genotype on inflammation and vitamin E status.
Topics: alpha-Tocopherol; Alzheimer Disease; Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Cardiovascular Diseases; Genotype; Germany; Humans; Inflammation; Mice; Polymorphism, Genetic; RNA, Messenger; Vitamin E | 2010 |
Role of C-reactive protein in the assessment of cardiovascular risk.
Topics: alpha-Tocopherol; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Obesity; Risk Factors; Weight Loss | 2003 |
Cardiology Grand Rounds from the University of North Carolina at Chapel Hill. The antioxidant vitamins and coronary heart disease: Part II. Randomized clinical trials.
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Aspirin; beta Carotene; Cardiovascular Diseases; Coronary Disease; Dietary Supplements; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Vitamins | 2003 |
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
Topics: alpha-Tocopherol; Antioxidants; beta Carotene; Cardiovascular Diseases; Cause of Death; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors | 2003 |
The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events.
Topics: alpha-Tocopherol; Animal Diseases; Animals; Antioxidants; Arteriosclerosis; Ataxia; Cardiovascular Diseases; Free Radicals; gamma-Tocopherol; Gene Expression Regulation; Humans; Male; Prostatic Neoplasms; Protein Processing, Post-Translational; Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic | 2003 |
Anti-inflammatory effects of alpha-tocopherol.
Topics: alpha-Tocopherol; Anti-Inflammatory Agents; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Cytokines; Humans; Monocytes; Plasminogen Activator Inhibitor 1; Risk Factors | 2004 |
Is all-rac-alpha-tocopherol different from RRR-alpha-tocopherol regarding cardiovascular efficacy? A meta-analysis of clinical trials.
Topics: alpha-Tocopherol; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Odds Ratio | 2004 |
Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?
Topics: alpha-Tocopherol; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arteriosclerosis; Biological Availability; Cardiovascular Diseases; gamma-Tocopherol; Humans; Intestinal Absorption; Oxidative Stress | 2005 |
Role of oxidative stress in development of cardiovascular complications in diabetes mellitus.
Topics: alpha-Tocopherol; Animals; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Dyslipidemias; Endothelium, Vascular; Glucose; Humans; Hyperglycemia; Hypertension; Insulin Resistance; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Risk Factors; Vitamin E | 2006 |
gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.
Topics: Aging; alpha-Tocopherol; Animals; Antioxidants; Biological Availability; Cardiovascular Diseases; Chromans; gamma-Tocopherol; Humans; Intestinal Absorption; Neoplasms; Nutritive Value; Propionates; Prostaglandin-Endoperoxide Synthases; Vitamin E Deficiency | 2001 |
Interventional study with vitamin E in cardiovascular disease and meta-analysis.
Topics: Antioxidants; Cardiovascular Diseases; Humans; Tocopherols; Tocotrienols; Vitamin E | 2022 |
Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studies.
Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Chronic Disease; Humans; Inflammation; Palm Oil; Tocotrienols; Vitamin E | 2022 |
Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity - A narrative review.
Topics: Antioxidants; Cardiovascular Diseases; Dietary Supplements; Female; Humans; Male; Obesity; Vitamin E | 2022 |
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
Topics: Adult; Advisory Committees; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Mass Screening; Minerals; Neoplasms; Nutrition Surveys; Risk Assessment; Vitamin E; Vitamins | 2022 |
A Review on Vitamin E Natural Analogues and on the Design of Synthetic Vitamin E Derivatives as Cytoprotective Agents.
Topics: Antioxidants; Biological Products; Cardiovascular Diseases; Drug Design; Humans; Neoplasms; Neurodegenerative Diseases; Protective Agents; Vitamin E | 2021 |
The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Genetic Predisposition to Disease; Genotype; Glycated Hemoglobin; Haptoglobins; Humans; Polymorphism, Genetic; Vitamin E; Vitamins | 2020 |
The role of biofactors in the prevention and treatment of age-related diseases.
Topics: Aged; Cardiovascular Diseases; Dementia; Diabetes Mellitus; Dietary Fiber; Dietary Supplements; Epigenesis, Genetic; Fatty Acids, Omega-3; Folic Acid; Humans; Neoplasms; Non-alcoholic Fatty Liver Disease; Thiamine; Thioctic Acid; Vitamin D; Vitamin E | 2021 |
Red Palm Oil: A Review on Processing, Health Benefits and Its Application in Food.
Topics: Antineoplastic Agents, Phytogenic; beta Carotene; Cardiovascular Diseases; Chemical Phenomena; Fatty Acids; Fatty Acids, Unsaturated; Food Handling; Humans; Liquid-Liquid Extraction; Nutritive Value; Palm Oil; Vitamin A Deficiency; Vitamin E | 2021 |
Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Supplements; Genotype; Haptoglobins; Humans; Oxidative Stress; Vitamin E | 2017 |
Effects of oxidized lipids and lipoproteins on cardiac function.
Topics: Antioxidants; Cardiovascular Diseases; Humans; Lipids; Lipoproteins, LDL; Myocytes, Cardiac; Oxidation-Reduction; Vitamin E | 2018 |
Dietary and circulating vitamin C, vitamin E, β-carotene and risk of total cardiovascular mortality: a systematic review and dose-response meta-analysis of prospective observational studies.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Biomarkers; Cardiovascular Diseases; Diet; Eating; Female; Humans; Male; Middle Aged; Nutritional Status; Observational Studies as Topic; Prospective Studies; Risk; Risk Factors; Vitamin E | 2019 |
Vitamin E: Regulatory role in the cardiovascular system.
Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Humans; Vitamin E | 2019 |
Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Odds Ratio; Publication Bias; Randomized Controlled Trials as Topic; Risk; Vitamin E; Vitamins | 2013 |
Patient selection and vitamin E treatment in diabetes mellitus.
Topics: Animals; Antioxidants; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Genotype; Haptoglobins; Humans; Incidence; Oxidative Stress; Patient Selection; Vitamin E | 2013 |
Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Haptoglobins; Humans; Patient Selection; Precision Medicine; Vitamin E | 2013 |
Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies.
Topics: Antioxidants; Ascorbic Acid; Bilirubin; Biomarkers; Cardiovascular Diseases; Carotenoids; Dietary Supplements; Glutathione; Humans; Nutritional Status; Oxidative Stress; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Serum Albumin; Vitamin E | 2013 |
Antioxidant supplements and mortality.
Topics: Antioxidants; beta Carotene; Cardiovascular Diseases; Chronic Disease; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Meta-Analysis as Topic; Neoplasms; Observational Studies as Topic; Randomized Controlled Trials as Topic; Vitamin A; Vitamin E | 2014 |
Meta-analysis: low-dose intake of vitamin E combined with other vitamins or minerals may decrease all-cause mortality.
Topics: Cardiovascular Diseases; Databases, Factual; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Mortality; Neoplasms; Randomized Controlled Trials as Topic; Trace Elements; Vitamin E; Vitamins | 2014 |
The Two Sides of Vitamin E Supplementation.
Topics: Aging; Antioxidants; Bone Remodeling; Cardiovascular Diseases; Dementia; Dietary Supplements; Humans; Neoplasms; Vitamin E | 2015 |
Effects of supplementation with the fat-soluble vitamins E and D on fasting flow-mediated vasodilation in adults: a meta-analysis of randomized controlled trials.
Topics: Adult; Cardiovascular Diseases; Dietary Supplements; Fasting; Humans; Vasodilation; Vitamin D; Vitamin E; Vitamins | 2015 |
Nonalcoholic fatty liver disease: new treatments.
Topics: Antioxidants; Cardiovascular Diseases; Dyslipidemias; Humans; Hypoglycemic Agents; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Risk Reduction Behavior; Thiazolidinediones; Vitamin E; Weight Loss | 2015 |
The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
Topics: Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Inflammation; Oxidative Stress; Reactive Oxygen Species; Risk Factors; Vitamin E | 2015 |
Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review.
Topics: Antioxidants; Cardiovascular Diseases; Diet, Mediterranean; Dietary Supplements; Fish Oils; Humans; Kidney Failure, Chronic; Observational Studies as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Vitamin B Complex; Vitamin E | 2015 |
The year in cardiology 2015: prevention.
Topics: Adrenocorticotropic Hormone; Antibodies, Monoclonal; Anticholesteremic Agents; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Diabetic Angiopathies; Disease Progression; Dyslipidemias; Global Health; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoprotein(a); PCSK9 Inhibitors; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Risk Assessment; Therapies, Investigational; Vitamin E | 2016 |
Nonalcoholic Fatty Liver Disease and Liver Transplantation.
Topics: Antioxidants; Body Mass Index; Body Weight; Cardiovascular Diseases; Comorbidity; Diet; Humans; Hypoglycemic Agents; Liver Transplantation; Non-alcoholic Fatty Liver Disease; Recurrence; Renal Insufficiency, Chronic; Survival Rate; Vitamin E | 2016 |
Vitamin E: Emerging aspects and new directions.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cytochrome P-450 Enzyme System; Humans; Inflammation; Oxidation-Reduction; Rats; Risk Factors; Vitamin E | 2017 |
Association between Micronutrients Intake/Status and Carotid Intima Media Thickness: A Systematic Review.
Topics: Antioxidants; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Carotid Intima-Media Thickness; Databases, Factual; Disease Progression; Humans; Iron; Magnesium; Micronutrients; Nutritional Status; Randomized Controlled Trials as Topic; Risk Factors; Vitamin A; Vitamin B Complex; Vitamin D; Vitamin E; Zinc | 2017 |
Health-promoting effects of red palm oil: evidence from animal and human studies.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Carotenoids; Disease Models, Animal; Evidence-Based Medicine; Fruit; Health Promotion; Humans; Palm Oil; Phytochemicals; Randomized Controlled Trials as Topic; Recommended Dietary Allowances; Squalene; Ubiquinone; Vitamin A Deficiency; Vitamin E | 2017 |
Antioxidant plasma concentration and supplementation in carotid intima media thickness.
Topics: Antioxidants; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Carotenoids; Carotid Arteries; Carotid Stenosis; Female; Humans; Male; Oxidative Stress; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Tunica Intima; Tunica Media; Ultrasonography; Vitamin A; Vitamin E | 2008 |
Vitamin E in human health and disease.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cytochrome P-450 CYP3A; Enzyme Induction; Humans; Lipoproteins; Oxidation-Reduction; Oxidative Stress; Placebos; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
How safe is vitamin E supplementation?
Topics: Cardiovascular Diseases; Dietary Supplements; Eye Diseases; Humans; Meta-Analysis as Topic; Neoplasms; Nervous System Diseases; Practice Guidelines as Topic; Respiratory Tract Infections; Vitamin E | 2008 |
Nutrient supplements and cardiovascular disease: a heartbreaking story.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Health; Humans; Vitamin D; Vitamin E | 2009 |
[Vitamins and minerals with antioxidant properties and cardiometabolic risk: controversies and perspectives].
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Dietary Supplements; Humans; Minerals; Oxidative Stress; Vitamin A; Vitamin E; Vitamins | 2009 |
Antiatherogenic effects of vitamin E: the search for the Holy Grail.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Evidence-Based Medicine; Humans; Research Design; Treatment Outcome; Vitamin E | 2009 |
Functional foods for dyslipidaemia and cardiovascular risk prevention.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Dyslipidemias; Fatty Acids; Functional Food; Humans; Hypertension; Hypolipidemic Agents; Magnoliopsida; Phytotherapy; Plant Extracts; Risk Factors; Vitamin E | 2009 |
Vitamin E and risk of cardiovascular diseases: a review of epidemiologic and clinical trial studies.
Topics: Antioxidants; Cardiovascular Diseases; Diet; Global Health; Humans; Vitamin E | 2010 |
An update on vitamin E, tocopherol and tocotrienol-perspectives.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Neoplasms; Tocopherols; Tocotrienols; Vitamin E; Vitamins | 2010 |
Antioxidant vitamins and their use in preventing cardiovascular disease.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Oxidative Stress; Vitamin E; Vitamins | 2010 |
Dietary lipophilic antioxidants: implications and significance in the aging process.
Topics: Antioxidants; Cardiovascular Diseases; Diet; Dietary Supplements; Free Radicals; Humans; Life Style; Longevity; Oxidative Stress; Resveratrol; Stilbenes; Ubiquinone; Vitamin A; Vitamin E | 2010 |
Antioxidant vitamins and cardiovascular disease.
Topics: Aged; Antioxidants; beta Carotene; Cardiovascular Diseases; Cohort Studies; Diet; Dietary Supplements; Female; Fruit; Humans; Male; Meta-Analysis as Topic; Middle Aged; Oxidation-Reduction; Oxidative Stress; Randomized Controlled Trials as Topic; Risk Factors; Vegetables; Vitamin E; Vitamins | 2011 |
Vitamin E in oxidant stress-related cardiovascular pathologies: focus on experimental studies.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Diabetic Cardiomyopathies; Disease Models, Animal; Humans; Oxidative Stress; Tissue Distribution; Vitamin E; Vitamins | 2011 |
Vitamin E-related inhibition of monocyte 5-lipoxygenase and cardiovascular outcome in maintenance hemodialysis patients.
Topics: Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Cardiovascular Diseases; Cell Proliferation; Clinical Trials as Topic; Dietary Supplements; Enzyme Inhibitors; Humans; Kidney Failure, Chronic; Myocytes, Smooth Muscle; Patents as Topic; Platelet Aggregation Inhibitors; Renal Dialysis; Uremia; Vitamin E | 2011 |
Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Dietary Supplements; Down-Regulation; Evidence-Based Medicine; Homocysteine; Humans; Research Design; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B Complex; Vitamin E | 2012 |
Antioxidant therapy in hemodialysis patients: a systematic review.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Oxidative Stress; Renal Dialysis; Vitamin E | 2012 |
Whole grain cereals: functional components and health benefits.
Topics: beta-Glucans; Cardiovascular Diseases; Carotenoids; Diabetes Mellitus, Type 2; Diet; Dietary Fiber; Edible Grain; Functional Food; Humans; Hydroxybenzoates; Hypertension; Inulin; Neoplasms; Obesity; Vitamin E | 2012 |
Carotenoids and vitamins C and E in the prevention of cardiovascular disease.
Topics: Antioxidants; Ascorbic Acid; Atherosclerosis; Cardiovascular Diseases; Carotenoids; Dietary Supplements; Humans; Oxidative Stress; Vitamin E | 2012 |
Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Genotype; Haptoglobins; Humans; Myocardial Infarction; Pharmacogenetics; Risk Factors; Stroke; Vitamin E | 2012 |
Which studies of therapy merit credence? Vitamin E and estrogen therapy as cautionary examples.
Topics: Aged; Alzheimer Disease; Antioxidants; Cardiovascular Diseases; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Middle Aged; Quality of Life; Risk; Vitamin E | 2002 |
[Basic aspects and measurement of the antioxidant vitamins A and E].
Topics: Adult; Antioxidants; Cardiovascular Diseases; Carotenoids; Chromatography; Free Radical Scavengers; Hematologic Diseases; Humans; Immune System; Infant; Inflammation; Lipid Peroxidation; Neoplasms; Nutritional Requirements; Oxidation-Reduction; Specimen Handling; Vegetables; Vitamin A; Vitamin E | 2002 |
Vitamin E in cardiovascular disease: has the die been cast?
Topics: Antioxidants; Cardiovascular Diseases; Coronary Artery Disease; Humans; Lipoproteins, LDL; Oxidation-Reduction; Risk Factors; Vitamin E | 2002 |
Tomatoes and cardiovascular health.
Topics: Antioxidants; Ascorbic Acid; Biological Availability; Cardiovascular Diseases; Carotenoids; Diet; Flavonoids; Folic Acid; Food Handling; Hot Temperature; Humans; Lycopene; Nutritive Value; Solanum lycopersicum; Vitamin E | 2003 |
Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials.
Topics: Antioxidants; Arteriosclerosis; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; Cholesterol, LDL; Humans; Lycopene; Oxidative Stress; Randomized Controlled Trials as Topic; Risk Assessment; Vitamin E; Vitamins | 2002 |
A review of vitamins A, C, and E and their relationship to cardiovascular disease.
Topics: Adult; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Child; Cholesterol, LDL; Counseling; Dietary Supplements; Energy Intake; Female; Humans; Male; Nutrition Policy; Oxidation-Reduction; Oxidative Stress; Patient Education as Topic; Primary Prevention; Risk Assessment; Risk Factors; United States; Vitamin A; Vitamin E | 1998 |
Does vitamin E supplementation prevent cardiovascular events?
Topics: Adult; Aged; Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Europe; Female; Humans; Male; Middle Aged; United States; Vitamin E | 2003 |
Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Diet; Endothelium, Vascular; Female; Follow-Up Studies; Free Radicals; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Oxidative Stress; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Factors; Smoking; Time Factors; Vitamin E | 2003 |
[The role of antioxidant vitamins C and E in cardiovascular therapy].
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Feeding Behavior; Female; Humans; Male; Vitamin E | 2003 |
[Antioxidant vitamins in the treatment and prevention of cardiovascular diseases. Vitamin E].
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Humans; Oxidation-Reduction; Risk Factors; Vitamin E | 2003 |
Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.
Topics: Cardiovascular Diseases; Cause of Death; Dietary Supplements; Evidence-Based Medicine; Fatty Acids, Omega-3; Humans; Lipids; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Vitamin E | 2004 |
Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Haptoglobins; Humans; Israel; Molecular Biology; Phenotype; Predictive Value of Tests; Risk Factors; Vitamin E | 2004 |
[Vitamin and minerals supplements--required for good health?].
Topics: Cardiovascular Diseases; Consensus; Dietary Supplements; Dose-Response Relationship, Drug; Female; Health Status; Humans; Male; Minerals; Nutritional Requirements; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Research; Vitamin E; Vitamins | 2004 |
Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease.
Topics: Adult; Aged; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Vitamin E | 2004 |
[Atherosclerosis and vascular calcification in hemodialysis patients].
Topics: Animals; Arteriosclerosis; Calcinosis; Calcium-Binding Proteins; Cardiovascular Diseases; Cause of Death; Extracellular Matrix Proteins; Humans; Lipid Metabolism; Matrix Gla Protein; Metabolic Diseases; Mice; Oxidative Stress; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis; Risk Factors; Uremia; Vitamin E | 2004 |
Nutrients and cardiovascular disease: no easy answers.
Topics: Animals; beta Carotene; Cardiovascular Diseases; Folic Acid; Humans; Vitamin E | 2005 |
[Do vitamins C and E protect against the development of carotid stenosis and cardiovascular disease?].
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotid Stenosis; Humans; Vitamin E | 2005 |
Scientific evidence to support a vitamin E and heart disease health claim: research needs.
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Heart Diseases; Humans; Kidney Failure, Chronic; Vitamin E | 2005 |
Vitamin E: absorption, plasma transport and cell uptake.
Topics: Antioxidants; Cardiovascular Diseases; Humans; Intestinal Absorption; Lipoproteins, LDL; Liver; Oxidation-Reduction; Vitamin E | 2005 |
Vitamin E modulation of cardiovascular disease.
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Cells, Cultured; Diet; Female; Humans; Inflammation; Lipid Peroxidation; Lipoproteins, LDL; Male; Oxidative Stress; Vitamin E | 2004 |
Vitamin E and cardiovascular disease: observational studies.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Diet; Dietary Supplements; Humans; Randomized Controlled Trials as Topic; Vitamin E | 2004 |
Vitamin E for the treatment of cardiovascular disease: is there a future?
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 2004 |
[Cardiology -- what is new?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure Monitoring, Ambulatory; Cardiology; Cardiovascular Diseases; Death, Sudden, Cardiac; Humans; Pacemaker, Artificial; Primary Prevention; Stem Cell Transplantation; Stents; Vitamin E | 2005 |
Alpha-tocopherol: roles in prevention and therapy of human disease.
Topics: Alzheimer Disease; Antioxidants; Biological Transport; Cardiovascular Diseases; Humans; Neoplasms; Oxidative Stress; Vitamin E | 2005 |
Antioxidants and cardiovascular disease.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hypercholesterolemia; Oxidative Stress; Risk Factors; Vitamin E | 2005 |
Vitamin E supplementation in cardiovascular disease and cancer prevention: Part 1.
Topics: Cardiovascular Diseases; Dietary Supplements; Humans; Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin E; Vitamins | 2005 |
[Recent changes in concepts of antioxidant treatment].
Topics: Acetylcysteine; Allopurinol; Antioxidants; Apoptosis; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Coenzymes; Flavonoids; Humans; Meta-Analysis as Topic; Neoplasms; Selenium; Ubiquinone; Vitamin A; Vitamin D; Vitamin E; Vitamin K; Vitamins | 2006 |
What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease.
Topics: Antioxidants; Cardiovascular Diseases; Cohort Studies; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Vitamin E | 2006 |
[Antioxidative properties of vitamin E as a new approach to its applications in therapy].
Topics: Antioxidants; Cardiovascular Diseases; Humans; Neoplasms; Oxidative Stress; Vitamin E | 2006 |
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part IV--is vitamin E phosphate or another unique type of this vitamin the last chance for these supplements?
Topics: Cardiovascular Diseases; Dietary Supplements; Humans; Vitamin E | 2006 |
Antioxidant vitamin supplementation in cardiovascular diseases.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Dietary Supplements; Humans; Vitamin A; Vitamin E | 2007 |
Nutritional strategies for healthy cardiovascular aging: focus on micronutrients.
Topics: Aging; Animals; Ascorbic Acid; Cardiovascular Diseases; Fatty Acids, Omega-3; Flavonoids; Humans; Lipoproteins, LDL; Micronutrients; Phenols; Polyphenols; Vitamin B Complex; Vitamin E | 2007 |
Smoking, oxidative stress and cardiovascular diseases--do anti-oxidative therapies fail?
Topics: Antioxidants; Ascorbic Acid; Atherosclerosis; Calcium; Cardiovascular Diseases; Humans; Inflammation; Oxidants; Oxidative Stress; Smoking; Vitamin E | 2007 |
Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
Topics: Acetophenones; Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Cardiovascular Diseases; Catalase; Cyclic N-Oxides; Enzyme Inhibitors; Female; Glutathione Peroxidase; Humans; Hypertension; Kidney; Male; Molsidomine; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Inbred SHR; Sex Factors; Spin Labels; Superoxide Dismutase; Vitamin E | 2007 |
Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
Topics: Antioxidants; Cardiovascular Diseases; Diabetic Angiopathies; Female; Haptoglobins; Humans; Male; Oxidative Stress; Pharmacogenetics; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Treatment Outcome; Vitamin E | 2007 |
Vitamin intake and risk of coronary disease: observation versus intervention.
Topics: Antioxidants; Atherosclerosis; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Dietary Supplements; Disease Progression; Humans; Incidence; Micronutrients; Primary Prevention; Vitamin B Complex; Vitamin D; Vitamin E; Vitamins | 2007 |
Vitamin therapy in the absence of obvious deficiency. What is the evidence?
Topics: Acne Vulgaris; Ascorbic Acid; Asthma; Cardiovascular Diseases; Common Cold; Fibrocystic Breast Disease; Humans; Neoplasms; Osteoporosis; Vitamin A; Vitamin B Complex; Vitamin D; Vitamin E; Vitamin K; Vitamins | 1984 |
Medical uses of vitamin E.
Topics: Adult; Anemia, Hemolytic; Anemia, Neonatal; Animals; Cardiovascular Diseases; Child; Diet; Female; Hematologic Diseases; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Intermittent Claudication; Intestinal Absorption; Malabsorption Syndromes; Male; Retinopathy of Prematurity; Vitamin E; Vitamin E Deficiency | 1983 |
Effect of dietary factors on prostanoids.
Topics: Cardiovascular Diseases; Diet; Dietary Fats; Fatty Acids; Feeding Behavior; Humans; Prostanoic Acids; Selenium; Vitamin E | 1984 |
Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand.
Topics: Adolescent; Adult; Aged; Aging; Animals; Cardiovascular Diseases; Child; Child, Preschool; Erythrocytes; Female; Fetal Blood; Food Analysis; Glutathione Peroxidase; Humans; Infant; Infant, Newborn; Male; Middle Aged; Muscular Diseases; Neoplasms; New Zealand; Nutritional Requirements; Parenteral Nutrition, Total; Pregnancy; Selenium; Soil; Vitamin E | 1980 |
Therapeutic uses of vitamin E in medicine.
Topics: Adult; Anemia; Animals; Antibody Formation; Antioxidants; Antitoxins; Blood Coagulation Disorders; Cardiovascular Diseases; Child; Erythrocytes, Abnormal; Female; Humans; Infant; Infant, Newborn; Male; Muscular Diseases; Nervous System Diseases; Respiratory Tract Diseases; Retinopathy of Prematurity; Vitamin E; Vitamin E Deficiency | 1980 |
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; Epidemiologic Methods; Humans; Randomized Controlled Trials as Topic; Vitamin E | 1995 |
Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: the need for randomized trials.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; Humans; Randomized Controlled Trials as Topic; Vitamin E | 1995 |
[Role of lipid oxidation in the development of atherosclerosis].
Topics: Antioxidants; Arteriosclerosis; Autoantigens; beta Carotene; Cardiovascular Diseases; Carotenoids; Coronary Artery Disease; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Vitamin E | 1994 |
[Is ubiquinone worth noticing?].
Topics: Aging; Antioxidants; Cardiovascular Diseases; Cholesterol, LDL; Humans; Sports Medicine; Ubiquinone; Vitamin E | 1994 |
Free radicals, oxidative stress, oxidized low density lipoprotein (LDL), and the heart: antioxidants and other strategies to limit cardiovascular damage.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Diet; Free Radicals; Humans; Lipoproteins, LDL; Oxidation-Reduction; Oxidative Stress; Vitamin E | 1995 |
Critical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Humans; Neoplasms; Risk Factors; Selenium; Vitamin E | 1995 |
Vitamin E.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Female; Humans; Immune System; Male; Neoplasms; Nutrition Policy; Risk Factors; Vitamin E; Vitamin E Deficiency | 1995 |
Vitamin E: molecular and biological function.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Free Radicals; Humans; Lipid Peroxidation; Neoplasms; Vitamin E | 1994 |
Oxygen free radicals and antioxidants: a review.
Topics: Antioxidants; Arthritis, Rheumatoid; beta Carotene; Cardiovascular Diseases; Carotenoids; Free Radicals; Humans; Neoplasms; Oxygen; Superoxides; Vitamin A; Vitamin E | 1994 |
Antioxidant nutrients and disease.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Free Radicals; Fruit; Humans; Neoplasms; Nutritional Physiological Phenomena; Reactive Oxygen Species; Vegetables; Vitamin A; Vitamin E | 1993 |
The importance of vitamin E in reducing cardiovascular risk.
Topics: Cardiovascular Diseases; Cholesterol, LDL; Humans; Nutritional Requirements; Oxidation-Reduction; Risk Factors; Vitamin E | 1995 |
Update on dietary antioxidants and cancer.
Topics: Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Humans; Neoplasms; Randomized Controlled Trials as Topic; Vitamin E | 1996 |
Is it time to say yes to antioxidants?
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Diet; Female; Humans; Male; Middle Aged; Risk Factors; Treatment Outcome; Vitamin E | 1996 |
Antioxidant dietary status and genetic cardiovascular risk, or how an adequate intake of a-tocopherol, selenium, taurine, magnesium and various other natural antioxidants may overcome the deleterious metabolic consequences related to the E4-4 type of apol
Topics: Antioxidants; Apolipoprotein E4; Apolipoproteins E; Arteriosclerosis; Cardiovascular Diseases; Diet; Finland; Humans; Magnesium; Norway; Taurine; Vitamin E | 1996 |
Beta-carotene, vitamin C, and vitamin E: the protective micronutrients.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Eye Diseases; Health Promotion; Humans; Neoplasms; Preventive Medicine; Vitamin E | 1996 |
Microcirculation, vitamin E and omega 3 fatty acids: an overview.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Fatty Acids, Omega-3; Humans; Mice; Microcirculation; Vitamin E | 1997 |
Antioxidant vitamins and cardiovascular disease.
Topics: Animals; Antioxidants; beta Carotene; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Vitamin E | 1997 |
Will the 'good fairies' please prove to us that vitamin E lessens human degenerative disease?
Topics: Antioxidants; Arteriosclerosis; Cardiovascular Diseases; DNA; Fatty Acids, Unsaturated; Free Radicals; Humans; Lipid Peroxides; Lipoproteins; Membrane Lipids; Neoplasms; Vitamin E | 1997 |
Vitamin E and human health: rationale for determining recommended intake levels.
Topics: Cardiovascular Diseases; Diet; Dietary Fats, Unsaturated; Fatty Acids, Unsaturated; Female; Humans; Immune System; Male; Neoplasms; Nutritional Requirements; Safety; Vitamin E; Vitamin E Deficiency | 1997 |
A closer look at vitamin E. Can this antioxidant prevent chronic diseases?
Topics: Cardiovascular Diseases; Humans; Immune System; Neoplasms; Vitamin E | 1997 |
Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Clinical Trials as Topic; Epidemiologic Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin E; Vitamins | 1997 |
Oxidative stress and cardiovascular disease.
Topics: Angioplasty, Balloon; Animals; Ascorbic Acid; Cardiovascular Diseases; Coronary Vessels; Oxidative Stress; Superoxides; Vitamin E | 1997 |
[Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach?].
Topics: Antioxidants; Cardiovascular Diseases; Drug Incompatibility; Humans; Kidney Failure, Chronic; Nitric Oxide; Oxidative Stress; Renal Dialysis; Vitamin E | 1997 |
Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence.
Topics: Animals; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Coronary Disease; Diet; Female; Free Radicals; Humans; Lipoproteins, LDL; Male; Oxidation-Reduction; Prospective Studies; Risk Factors; Selenium; Vitamin E | 1997 |
Antioxidant vitamins and cardiovascular disease: current knowledge and future directions.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Female; Humans; Male; Randomized Controlled Trials as Topic; Vitamin E | 1998 |
New developments in cardiovascular drugs: vitamin E and antioxidants--an informal and personal viewpoint.
Topics: Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Diet; Humans; Vitamin E | 1997 |
Will the 'good fairies' please prove to us that vitamin E lessens human degenerative disease?
Topics: Aging, Premature; Animals; Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Humans; Neoplasms; Vitamin E | 1997 |
Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Health Promotion; Humans; Micronutrients; Neoplasms; Nutritional Physiological Phenomena; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 1998 |
[Antioxidative vitamins: prevention of cardiovascular diseases].
Topics: Arteriosclerosis; Ascorbic Acid; Cardiovascular Diseases; Humans; Primary Prevention; Prospective Studies; Vitamin A; Vitamin E | 1998 |
Antioxidant vitamins and cardiovascular disease: Dr Jekyll or Mr Hyde?
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diet; Drug Therapy, Combination; Humans; Risk Factors; Vitamin E | 1999 |
Use of antioxidants in the prevention and treatment of disease.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diabetes Mellitus; Humans; Oxidative Stress; Respiratory Distress Syndrome; Vitamin E | 1998 |
Evidence based cardiology: emerging approaches in preventing cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular Diseases; Evidence-Based Medicine; Homocysteine; Humans; Oxidative Stress; Risk Assessment; Risk Factors; Vitamin E | 1999 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
[Carotenoids: 2. Diseases and supplementation studies].
Topics: Anticarcinogenic Agents; Cardiovascular Diseases; Carotenoids; China; Dietary Supplements; Humans; Neoplasms; Retinal Diseases; Skin Diseases; Vitamin E | 1999 |
Haemolipodialysis.
Topics: Ascorbic Acid; Cardiovascular Diseases; Humans; Liposomes; Oxidative Stress; Renal Dialysis; Vitamin E | 1999 |
Optimal nutrition: vitamin E.
Topics: Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Humans; Lipoproteins, LDL; Neoplasms; Nutritional Physiological Phenomena; Nutritional Status; Reference Values; Vitamin E | 1999 |
Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Humans; Lipoproteins, LDL; Randomized Controlled Trials as Topic; Vitamin E | 1999 |
Tocotrienol: a review of its therapeutic potential.
Topics: Animals; Cardiovascular Diseases; Humans; Neoplasms; Vitamin E | 1999 |
Vitamins for the management of cardiovascular disease: a simple solution to a complex problem?
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Myocardial Infarction; Vitamin B Complex; Vitamin E; Vitamins | 1999 |
[Antioxidants and cardiovascular disease].
Topics: Antioxidants; Cardiovascular Diseases; Female; Humans; Male; Vitamin E | 1999 |
Vitamin E and heart disease: basic science to clinical intervention trials.
Topics: Adult; Aged; Angiography; Animals; Antioxidants; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Clinical Trials as Topic; Cohort Studies; Diet, Atherogenic; Double-Blind Method; Drug Synergism; Female; Free Radicals; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prospective Studies; Rabbits; Randomized Controlled Trials as Topic; Risk; Safety; Stroke; Vitamin E; Vitamins | 2000 |
Nutritional strategies in cardiovascular disease control: an update on vitamins and conditionally essential nutrients.
Topics: Antioxidants; Arginine; Ascorbic Acid; Cardiovascular Diseases; Carnitine; Coenzymes; Cost-Benefit Analysis; Free Radical Scavengers; Humans; Nutritional Requirements; Primary Prevention; Ubiquinone; Vitamin B Complex; Vitamin E | 1999 |
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.
Topics: Aged; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cataract; Double-Blind Method; Female; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Neoplasms; Sample Size; Vitamin E | 2000 |
Should the results of the HOPE study affect nephrological practice? For the HOPE investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Drug Therapy, Combination; Hemodynamics; Humans; Kidney Diseases; Kidney Function Tests; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 2000 |
The antioxidant paradox.
Topics: Animals; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Free Radicals; Humans; Lipid Peroxidation; Neoplasms; Vitamin E | 2000 |
Effect of functional food ingredients: vitamin E modulation of cardiovascular diseases and immune status in the elderly.
Topics: Adult; Aged; Aging; Antioxidants; Cardiovascular Diseases; Diet; Food; Free Radicals; Humans; Risk Factors; Vitamin E | 2000 |
[Should antioxidants be recommended for the prevention of cardiovascular diseases?].
Topics: Antioxidants; beta Carotene; Cardiovascular Diseases; Flavonoids; Humans; Probucol; Vitamin E | 2000 |
Beta-carotene, vitamin C, and vitamin E and cardiovascular diseases.
Topics: Animals; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Endothelium, Vascular; Humans; Male; Myocardial Ischemia; Randomized Controlled Trials as Topic; Vitamin E | 2000 |
Therapeutic potential of vitamin E in heart disease.
Topics: Animals; Antioxidants; Arteriosclerosis; Blood Vessels; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Oxidation-Reduction; Vitamin E | 2000 |
Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Humans; Lipoxygenase; Mice; Mice, Knockout; Myocardial Infarction; Species Specificity; Stroke; Thrombosis; Vitamin E | 2000 |
Vitamin E inhibition of platelet aggregation is independent of antioxidant activity.
Topics: Antioxidants; Blood Platelets; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Protein Kinase C; Thrombosis; Vitamin E | 2001 |
Vitamin E and macrophage cyclooxygenase regulation in the aged.
Topics: Aged; Aging; Animals; Arachidonic Acid; Cardiovascular Diseases; Cells, Cultured; Gene Expression Regulation, Enzymologic; Humans; Macrophages; Mice; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Time Factors; Transcription, Genetic; Up-Regulation; Vitamin E | 2001 |
Is there a vitamin E paradox?
Topics: Adult; Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Platelet Aggregation; Vitamin E | 2001 |
[How should ACE inhibitors be used in myocardial infarction?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Follow-Up Studies; Humans; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 2000 |
Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Coronary Disease; Diet; Homocysteine; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Vitamin E | 2000 |
Oxidative stress and the role of antioxidants in cardiovascular risk reduction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; Coenzymes; Free Radicals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lycopene; Oxidative Stress; Primary Prevention; Risk Factors; Ubiquinone; Vitamin E | 2001 |
[The best in 2000 on clinical pharmacology].
Topics: Aspirin; Cardiovascular Diseases; Forecasting; Heart Diseases; Heparin; Hormone Replacement Therapy; Humans; Hypolipidemic Agents; Risk Factors; Vitamin E | 2001 |
Oxidative stress and cardiovascular disease in hemodialysis.
Topics: Acute-Phase Proteins; Biomarkers; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Nitric Oxide; Oxidative Stress; Renal Dialysis; Vitamin E | 2001 |
Dietary modulation of endothelial function: implications for cardiovascular disease.
Topics: Antioxidants; Arginine; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diet; Endothelium, Vascular; Epidemiologic Studies; Fatty Acids, Omega-3; Fish Oils; Folic Acid; Humans; MEDLINE; Oxidative Stress; Risk Factors; Vitamin E | 2001 |
The role of folate, antioxidant vitamins and other constituents in fruit and vegetables in the prevention of cardiovascular disease: the epidemiological evidence.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Epidemiologic Studies; Folic Acid; Fruit; Homocysteine; Humans; Vegetables; Vitamin E | 2001 |
Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
Topics: Anticholesteremic Agents; Biological Products; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Fatty Acids; Female; Flavonoids; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Naphthalenes; Olive Oil; Phenols; Phosphorus; Plant Oils; Polymers; Polyphenols; Proteins; Starch; Vitamin E | 2001 |
Antioxidant strategy for cardiovascular diseases.
Topics: Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vitamin E | 2001 |
Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Lipid Peroxidation; Lipoproteins, LDL; Models, Animal; Oxidative Stress; Vitamin E | 2001 |
Micronutrients: oxidant/antioxidant status.
Topics: Antioxidants; Arthritis, Rheumatoid; Ascorbic Acid; Cardiovascular Diseases; Copper; Deficiency Diseases; Developing Countries; Disease Susceptibility; HIV Infections; Humans; Iron; Magnesium; Manganese; Micronutrients; Nutritional Status; Oxidative Stress; Virus Diseases; Vitamin E; Zinc | 2001 |
Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes.
Topics: Antioxidants; Blood Glucose; Cardiovascular Diseases; Developed Countries; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Incidence; Obesity; Oxidative Stress; Thioctic Acid; Vitamin E | 2001 |
Vitamin E and omega-3 fatty acids: effectors of platelet responsiveness.
Topics: Blood Platelets; Cardiovascular Diseases; Fatty Acids, Omega-3; Humans; Platelet Aggregation; Signal Transduction; Vitamin E | 2001 |
[Antioxidant vitamins - importance for cardiopulmonary prophylaxis. Part II. Antioxidant food supplies - vitamin C and beta-carotene; current experience in antioxidant vitamin usage].
Topics: Antioxidants; Arteriosclerosis; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Lipoproteins, LDL; Oxidative Stress; Vitamin E | 2000 |
Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Clinical Trials as Topic; Female; Humans; Lipid Peroxidation; Male; MEDLINE; Randomized Controlled Trials as Topic; Vitamin E; Vitamins | 2001 |
Platelets and oxygen radicals: mechanisms of functional modulation.
Topics: Antioxidants; Blood Platelets; Cardiovascular Diseases; Diet; Flavonoids; Humans; Platelet Activation; Reactive Oxygen Species; Vitamin E | 2001 |
Lipid peroxidation, vitamin E, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Epoprostenol; Humans; Lipid Peroxidation; Lipid Peroxides; Vitamin E | 1992 |
93 trial(s) available for d-alpha tocopherol and Cardiovascular Diseases
Article | Year |
---|---|
Low-volume exercise training and vitamin E supplementation attenuates oxidative stress in postmenopausal women.
Topics: Aged; Aging; alpha-Tocopherol; Antioxidants; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Exercise; Female; Health Promotion; Humans; Japan; Middle Aged; Oxidative Stress; Postmenopause; Reactive Oxygen Species; Risk; Thioredoxins; Vitamin E; Walking | 2013 |
Baseline oxidative defense and survival after 5-7 years among elderly stroke patients at nutritional risk: Follow-up of a randomized, nutritional intervention trial.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Carotenoids; Diet; Dietary Proteins; Energy Intake; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Oxidative Stress; Proportional Hazards Models; Stroke | 2015 |
Do dry roasting, lightly salting nuts affect their cardioprotective properties and acceptability?
Topics: Adult; alpha-Tocopherol; Apolipoprotein A-I; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Corylus; Cross-Over Studies; Diet; Dietary Fats; Dietary Proteins; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; Food Handling; Humans; Male; Middle Aged; Nuts; Patient Compliance; Risk Factors; Sodium Chloride, Dietary; Triglycerides | 2017 |
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Vitamin E; Vitamins | 2008 |
Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients.
Topics: Administration, Oral; Adult; alpha-Tocopherol; Antioxidants; Cardiovascular Diseases; Cholesterol; Chronic Disease; Dietary Supplements; Female; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Renal Dialysis; Risk Factors | 2009 |
Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population.
Topics: alpha-Tocopherol; Antioxidants; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Choice Behavior; Cross-Over Studies; Diet; Dietary Fiber; Endothelium, Vascular; Feeding Behavior; Female; Food Preferences; Fruit; gamma-Glutamyltransferase; Humans; Male; Middle Aged; Risk Factors; Vegetables | 2012 |
Effects of a high-protein, low-carbohydrate v. high-protein, moderate-carbohydrate weight-loss diet on antioxidant status, endothelial markers and plasma indices of the cardiometabolic profile.
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Cross-Over Studies; Cryptoxanthins; Diet, Carbohydrate-Restricted; Diet, Reducing; Dietary Carbohydrates; Dietary Proteins; Endothelium, Vascular; Energy Intake; Humans; Hyperlipidemias; Inflammation Mediators; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nutritional Requirements; Obesity; Risk Factors; Vitamin A; Weight Loss; Xanthophylls | 2011 |
Decreased carotenoid concentrations due to dietary sucrose polyesters do not affect possible markers of disease risk in humans.
Topics: Adolescent; Adult; Aged; alpha-Tocopherol; beta Carotene; Body Weight; Cardiovascular Diseases; Carotenoids; Dietary Fats, Unsaturated; Double-Blind Method; Endothelium, Vascular; Eye Diseases; Fatty Acids; Female; Health Status; Humans; Immunity; Lipid Peroxidation; Lipids; Macula Lutea; Male; Middle Aged; Patient Compliance; Placebos; Risk Factors; Sucrose; Xanthophylls; Zeaxanthins | 2003 |
Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community.
Topics: Aged; Aged, 80 and over; Aging; alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diet; Diet Records; Dietary Supplements; Female; Humans; Male; Mortality; Nutrition Assessment; Nutritional Physiological Phenomena; Proportional Hazards Models; Risk Factors; Surveys and Questionnaires; Vitamin A; Vitamins | 2003 |
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Dietary Supplements; DNA Damage; Folic Acid; Folic Acid Deficiency; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Micronucleus Tests; Middle Aged; Myocardial Infarction; Oxidative Stress; Selenium | 2004 |
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
Topics: Aged; alpha-Tocopherol; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Risk; Vascular Diseases | 2005 |
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
Topics: Aged; alpha-Tocopherol; Aspirin; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Drug Interactions; Female; Humans; Incidence; Middle Aged; Mortality; Neoplasms; Primary Prevention; Risk Factors | 2005 |
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects.
Topics: Acute-Phase Reaction; alpha-Tocopherol; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dietary Supplements; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Oxidation-Reduction; Stereoisomerism | 2006 |
Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease.
Topics: Aged; alpha-Tocopherol; beta Carotene; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dinoprost; Female; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Oxidative Stress; Risk | 2008 |
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
Topics: alpha-Tocopherol; Antioxidants; Apolipoproteins; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Coronary Stenosis; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Selenium; Simvastatin; Vitamin E | 2001 |
The Effect of Omega-3 Fatty Acid Supplementation on Serum Adipocytokines, Lipid Profile and Biochemical Markers of Inflammation in Recreational Runners.
Topics: Adipokines; Adult; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Erythrocytes; Fatty Acids, Omega-3; Humans; Inflammation Mediators; Lipids; Male; Neuregulins; Oxidative Stress; Running; Vitamin D; Vitamin E | 2021 |
Cardiovascular risk and benefits from antioxidant dietary intervention with red wine in asymptomatic hypercholesterolemics.
Topics: Adult; Aged; Antioxidants; Asymptomatic Diseases; Biomarkers; Cardiovascular Diseases; Cholesterol; Female; Greece; Humans; Hypercholesterolemia; Male; Middle Aged; Protective Factors; Risk Factors; Time Factors; Treatment Outcome; Vitamin E; Wine; Young Adult | 2015 |
The effect of almonds on vitamin E status and cardiovascular risk factors in Korean adults: a randomized clinical trial.
Topics: Aged; Cardiovascular Diseases; Cholesterol, LDL; Cross-Over Studies; Female; Humans; Male; Middle Aged; Prunus dulcis; Republic of Korea; Risk Factors; Vitamin E | 2018 |
Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and
Topics: Aged; Antineoplastic Agents; Apolipoprotein A-I; Aspirin; Cardiovascular Diseases; Cholesterol, HDL; Coronary Disease; Double-Blind Method; England; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Risk Factors; Vitamin E; Women's Health | 2017 |
Low Intake of Vitamin E Accelerates Cellular Aging in Patients With Established Cardiovascular Disease: The CORDIOPREV Study.
Topics: Cardiovascular Diseases; Cellular Senescence; Diet, Mediterranean; Female; Fish Products; Genetic Markers; Glutathione Peroxidase; Humans; Leukocytes; Male; Middle Aged; Olive Oil; Oxidative Stress; Prospective Studies; Real-Time Polymerase Chain Reaction; Recommended Dietary Allowances; Telomere Shortening; Vitamin E | 2019 |
Plasma metabolomics of children with aberrant serum lipids and inadequate micronutrient intake.
Topics: Biomarkers; Calcium; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Folic Acid; Humans; Lipid Metabolism; Magnesium; Male; Metabolomics; Micronutrients; Nutritional Status; Prognosis; Recommended Dietary Allowances; Risk; Tandem Mass Spectrometry; Triglycerides; Vitamin D; Vitamin E | 2018 |
Sesame oil and vitamin E co-administration may improve cardiometabolic risk factors in patients with metabolic syndrome: a randomized clinical trial.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Insulin Resistance; Lipids; Male; Malondialdehyde; Metabolic Syndrome; Middle Aged; Risk Factors; Sesame Oil; Single-Blind Method; Vitamin E | 2019 |
Independent and Additive Effects of Coenzyme Q10 and Vitamin E on Cardiometabolic Outcomes and Visceral Adiposity in Women With Polycystic Ovary Syndrome.
Topics: Adiposity; Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Female; Humans; Obesity, Abdominal; Polycystic Ovary Syndrome; Triglycerides; Ubiquinone; Vitamin E | 2019 |
NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Female; Humans; Lipoproteins, HDL; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pioglitazone; Risk; Thiazolidinediones; Triglycerides; Vitamin E | 2015 |
Study of the effects of a diet supplemented with active components on lipid and glycemic profiles.
Topics: Adult; beta-Glucans; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Diet; Dietary Supplements; Fasting; Fatty Acids, Omega-3; Female; Humans; Insulin; Male; Meals; Overweight; Phytosterols; Postprandial Period; Risk Factors; Triglycerides; Vitamin E; Young Adult | 2015 |
Prospective study of plasma homocysteine level and risk of age-related macular degeneration in women.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Drug Combinations; Female; Follow-Up Studies; Homocysteine; Humans; Macular Degeneration; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires; United States; Visual Acuity; Vitamin E; Vitamins; Women's Health | 2015 |
Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Topics: Aged; Antioxidants; Aspirin; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Female; Humans; Incidence; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Sex Factors; Vitamin E | 2015 |
Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
Topics: Aged; Aspirin; Biomarkers; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Massachusetts; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Neoplasms; Peptide Fragments; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Troponin T; Vitamin E; Vitamins; Women's Health | 2016 |
A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
Topics: Aged; Aspirin; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Ethnicity; Female; Humans; Hypoglycemic Agents; Incidence; Middle Aged; Patient Compliance; Placebos; Primary Prevention; Racial Groups; Risk Assessment; Vitamin E | 2009 |
Vitamin C treatment reduces elevated C-reactive protein.
Topics: Adult; Age Factors; Ascorbic Acid; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Ethnicity; Female; Humans; Male; Menopause; Middle Aged; Sex Factors; Vitamin E | 2009 |
Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action.
Topics: Aged; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Cardiovascular Diseases; Cytokines; Diabetes Mellitus, Type 2; Dietary Supplements; Fasting; Humans; Insulin; Insulin Resistance; Lipids; Male; Oxidative Stress; Vitamin E | 2008 |
Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Middle Aged; Neoplasms; Primary Prevention; Proportional Hazards Models; Risk Assessment; Risk Factors; United States; Vitamin E | 2009 |
Effects of chronic and acute consumption of fruit- and vegetable-puree-based drinks on vasodilation, risk factors for CVD and the response as a result of the eNOS G298T polymorphism.
Topics: Adult; Ascorbic Acid; Beverages; Blood Glucose; Cardiovascular Diseases; Carotenoids; Cross-Over Studies; Diet; Endothelium, Vascular; Female; Fruit; Genotype; Humans; Insulin; Male; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Risk Factors; Vasodilation; Vegetables; Vitamin E | 2009 |
The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Cardiovascular Diseases; Chronic Disease; Death, Sudden; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Europe; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; North America; Proportional Hazards Models; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vascular Diseases; Vitamin E | 2009 |
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis.
Topics: Adult; Antihypertensive Agents; Antioxidants; Arthritis, Rheumatoid; Biomarkers; Blood Pressure; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iran; Linoleic Acids, Conjugated; Lipids; Male; Middle Aged; Treatment Outcome; Vitamin E | 2008 |
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study.
Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cognition Disorders; Female; Follow-Up Studies; Humans; Memory Disorders; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Oxidative Stress; Risk Factors; Single-Blind Method; Treatment Failure; Vitamin E | 2009 |
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.
Topics: Adult; Aged; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Middle Aged; Placebos; Proportional Hazards Models; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Odds Ratio; Oxidative Stress; Primary Prevention; Risk Assessment; Risk Factors; United States; Vitamin E | 2009 |
A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases.
Topics: Ascorbic Acid; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cooking; Cross-Over Studies; Diabetes Mellitus, Type 2; Fatty Acids, Omega-3; Female; Hot Temperature; Humans; Inflammation; Insulin; Life Style; Maillard Reaction; Male; Risk Factors; Triglycerides; Vitamin E; Young Adult | 2010 |
Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.
Topics: Adult; Antioxidants; Arginine; Ascorbic Acid; beta Carotene; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Double-Blind Method; Homocysteine; Humans; Male; Middle Aged; Protective Agents; Triglycerides; Vitamin B Complex; Vitamin E | 2010 |
L-arginine and antioxidant vitamins E and C improve the cardiovascular performance of broiler chickens grown under chronic hypobaric hypoxia.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Arginine; Ascorbic Acid; Cardiovascular Diseases; Diet; Dietary Supplements; Hypoxia; Poultry Diseases; Pressure; Time Factors; Vitamin E | 2010 |
Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study.
Topics: Aspirin; Asthma; Bronchitis, Chronic; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Humans; Longitudinal Studies; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Risk Factors; Vitamin E | 2010 |
Effect of vitamin E and C supplements on antioxidant defense system in cardiovascular disease patients in Zahedan, southeast Iran.
Topics: Aged; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Case-Control Studies; Dietary Supplements; Drug Therapy, Combination; Female; Free Radical Scavengers; Glutathione Peroxidase; Humans; Iran; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase; Vitamin E; Vitamins | 2010 |
Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers.
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Exercise; Female; Humans; Inflammation; Lipids; Male; Middle Aged; Oxidative Stress; Surveys and Questionnaires; Vitamin E; Young Adult | 2012 |
Argan oil improves surrogate markers of CVD in humans.
Topics: Adult; Algeria; Antioxidants; Biomarkers; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Dietary Supplements; Fruit; Humans; Lipids; Phytotherapy; Plant Oils; Sapotaceae; Triglycerides; Vitamin E | 2012 |
Optimized rapeseed oil enriched with healthy micronutrients: a relevant nutritional approach to prevent cardiovascular diseases. Results of the Optim'Oils randomized intervention trial.
Topics: Adult; Aged; alpha-Linolenic Acid; Apolipoproteins; Biomarkers; Body Mass Index; Brassica rapa; Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Double-Blind Method; Fatty Acids, Monounsaturated; Food, Fortified; Humans; Male; Margarine; Micronutrients; Middle Aged; Oxidative Stress; Phytosterols; Plant Oils; Rapeseed Oil; Triglycerides; Ubiquinone; Vitamin E | 2013 |
LDL cholesterol-lowering effects of grape extract used as a dietary supplement on healthy volunteers.
Topics: Adult; Antioxidants; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Female; Fruit; Humans; Male; Middle Aged; Oxidative Stress; Phytotherapy; Plant Extracts; Polyphenols; Reference Values; Vitamin E; Vitis | 2013 |
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cause of Death; Cholesterol; Coronary Disease; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Severity of Illness Index; Stroke; United Kingdom; Vitamin E | 2002 |
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Heart Diseases; Humans; Male; Myocardial Infarction; Placebos; Stroke; Survival Rate; Treatment Outcome; Vitamin E | 2002 |
Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Chromans; Dietary Supplements; Dinoprost; Double-Blind Method; F2-Isoprostanes; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Risk Factors; Tocopherols; Tocotrienols; Vitamin E | 2002 |
Prevalence of dry eye syndrome among US women.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Dry Eye Syndromes; Female; Health Occupations; Health Surveys; Humans; Middle Aged; Neoplasms; Prevalence; Surveys and Questionnaires; United States; Vitamin E; Women's Health | 2003 |
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Topics: Aged; Aspirin; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Risk Factors; Safety; Smoking; Vitamin E | 2003 |
Coenzyme Q10-containing composition (Immugen) protects against occupational and environmental stress in workers of the gas and oil industry.
Topics: Adult; Cardiovascular Diseases; Coenzymes; Dietary Supplements; Emotions; Environment; Female; Humans; Industrial Oils; Leukocytes; Luminescent Measurements; Luminol; Male; Methionine; Middle Aged; Nervous System Diseases; Occupational Exposure; Oxidative Stress; Peroxynitrous Acid; Petroleum; Phospholipids; Russia; Selenium; Siberia; Superoxides; Tetradecanoylphorbol Acetate; Ubiquinone; Vitamin E | 2003 |
Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women.
Topics: Adult; Apolipoprotein A-I; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dietary Fats; Energy Intake; Fatty Acids; Female; Humans; Male; Nutritional Requirements; Nutritional Status; Risk Factors; Triglycerides; Vitamin E; Zinc | 2004 |
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
Topics: Aged; Antioxidants; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Risk Factors; Severity of Illness Index; Stroke; Treatment Failure; Vitamin E | 2004 |
The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with Type 2 diabetes.
Topics: Aged; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erythrocytes; Female; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Lipid Peroxides; Lipids; Middle Aged; Postmenopause; Vitamin E | 2004 |
Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia.
Topics: Aged; Animals; Antioxidants; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Malondialdehyde; Middle Aged; Milk; Oleic Acid; Risk Factors; Spain; Time Factors; Vascular Cell Adhesion Molecule-1; Vitamin B 6; Vitamin B Complex; Vitamin E | 2004 |
Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
Topics: Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Renal Replacement Therapy; Vitamin E | 2004 |
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular Diseases; Female; Humans; Incidence; Male; Middle Aged; Morbidity; Myocardial Infarction; Preventive Medicine; Ramipril; Risk Factors; Smoking; Stroke; Treatment Outcome; Vitamin E | 2005 |
[Influence of oral sodium selenite and vitamin E on thyroid hormones in patients with cardiovascular disease at altitude].
Topics: Adult; Altitude; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Sodium Selenite; Thyroid Hormones; Vitamin E | 2004 |
Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Hydroxycholesterols; Inflammation; Ketocholesterols; Kidney Failure, Chronic; Male; Malnutrition; Middle Aged; Oxidative Stress; Renal Dialysis; Tunica Media; Vitamin E | 2005 |
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Fasting; Female; Glycated Hemoglobin; Humans; Kidney Diseases; Male; Placebos; Ramipril; Reference Values; Risk Factors; Vitamin E | 2005 |
Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
Topics: Administration, Oral; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; E-Selectin; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Kidney Failure, Chronic; Male; Middle Aged; Pregnancy-Associated Plasma Protein-A; Renal Dialysis; Vitamin E | 2006 |
Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer.
Topics: Aged; Aspirin; Cardiovascular Diseases; Chemoprevention; Female; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Placebos; Stroke; Vitamin E | 2006 |
Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation.
Topics: Adult; Antioxidants; Ascorbic Acid; beta Carotene; Beverages; Cardiovascular Diseases; Carotenoids; Cholesterol; Cholesterol, LDL; Diet; Female; Humans; Lipids; Lycopene; Male; Middle Aged; Oxidation-Reduction; Solanum lycopersicum; Vitamin E | 2007 |
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study.
Topics: Aspirin; Body Mass Index; Cardiovascular Diseases; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Double-Blind Method; Estradiol; Female; Glycated Hemoglobin; Humans; Middle Aged; Postmenopause; Risk Factors; Testosterone; Vitamin E | 2007 |
Vitamin E dietary supplementation significantly affects multiple risk factors for cardiovascular disease in baboons.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cross-Over Studies; Diet, Atherogenic; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Lipid Metabolism; Lipoproteins; Oxidative Stress; Papio; Prevalence; Risk Factors; Vitamin E | 2007 |
Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
Topics: Age Factors; Aged; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Genetic Markers; Genotype; Haptoglobins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Prognosis; Reference Values; Risk Assessment; Sex Factors; Survival Rate; Treatment Outcome; Vitamin E | 2008 |
Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients.
Topics: Adult; Aged; Antioxidants; Apolipoproteins B; Beverages; Biomarkers; Cardiovascular Diseases; Chemokine CCL2; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Female; Flavonoids; Humans; Intercellular Adhesion Molecule-1; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; NADPH Oxidases; Neutrophils; Oxidative Stress; Phenols; Polyphenols; Renal Dialysis; Risk Factors; Superoxides; Vitamin E; Vitis | 2008 |
Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view.
Topics: Aspirin; beta Carotene; Cardiovascular Diseases; Carotenoids; Female; Humans; Middle Aged; Primary Prevention; Randomized Controlled Trials as Topic; Research Design; Vitamin E | 1994 |
A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; Double-Blind Method; Female; Humans; Middle Aged; Research Design; Risk Factors; United States; Vitamin E | 1995 |
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Patient Selection; Ramipril; Research Design; Risk Factors; Vitamin E | 1996 |
The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients.
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lipid Peroxidation; Male; Risk Factors; Vitamin E | 1996 |
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Preven
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Factor Analysis, Statistical; Humans; Middle Aged; Placebos; Ramipril; Research Design; Risk Factors; Time Factors; Vitamin E | 1996 |
The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors.
Topics: Antioxidants; Arteriosclerosis; Ascorbic Acid; beta Carotene; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Lipids; Male; Middle Aged; Pilot Projects; Risk Factors; Time Factors; Vitamin E | 1997 |
Selenium and antioxidant vitamin and lipidoperoxidation levels in preaging French population. EVA Study Group. Edude de vieillissement artériel.
Topics: Aged; Aging; Antioxidants; Cardiovascular Diseases; Carotenoids; Female; France; Humans; Lipid Peroxidation; Longitudinal Studies; Male; Middle Aged; Risk Factors; Selenium; Thiobarbituric Acid Reactive Substances; Vitamin E | 1997 |
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Topics: Acute Disease; Adult; Antioxidants; Arginine; Ascorbic Acid; Blood Coagulation; Blood Viscosity; Cardiovascular Diseases; Cross-Over Studies; Endothelium, Vascular; Female; Hemodynamics; Homocysteine; Humans; Male; Methionine; Platelet Aggregation; Risk Factors; Single-Blind Method; Vitamin E | 1999 |
Vitamin E improves arterial compliance in middle-aged men and women.
Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Diet; Double-Blind Method; Elasticity; Female; Follow-Up Studies; Humans; Lipids; Male; Middle Aged; Reference Values; Risk Factors; Surveys and Questionnaires; Ultrasonography, Doppler; Vascular Resistance; Vitamin E | 1999 |
Vascular effects of estrogen and vitamin E therapies in postmenopausal women.
Topics: Analysis of Variance; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Estradiol; Estrone; Female; Fibrinolysis; Homeostasis; Humans; Inflammation; Lipid Metabolism; Middle Aged; Nitric Oxide; Postmenopause; Vasodilator Agents; Vitamin E | 1999 |
Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Double-Blind Method; Hemorrhage; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Protein Kinase C; Recurrence; Time Factors; Vitamin E | 1999 |
Vitamin E supplementation and cardiovascular events in high-risk patients.
Topics: Aged; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Mortality; Myocardial Infarction; Risk Factors; Stroke; Treatment Failure; Vitamin E | 2000 |
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.
Topics: Aged; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cataract; Double-Blind Method; Female; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Neoplasms; Sample Size; Vitamin E | 2000 |
The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Risk Factors; Treatment Outcome; Vitamin E | 2000 |
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.
Topics: Aged; Antioxidants; Cardiovascular Diseases; Deglutition; Double-Blind Method; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pruritus; Renal Dialysis; Survival Analysis; Treatment Outcome; Vitamin E | 2000 |
Correlates of serum alpha- and gamma-tocopherol in the Women's Health Initiative.
Topics: Aged; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diet; Female; Humans; Life Style; Middle Aged; Neoplasms; Postmenopause; Surveys and Questionnaires; Triglycerides; Vitamin E; Women's Health | 2001 |
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Family Practice; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Risk Factors; Vitamin E | 2001 |
Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers.
Topics: Aged; Antioxidants; Autoantibodies; Blood Cells; Cardiovascular Diseases; Cholesterol, LDL; Cytochrome c Group; Double-Blind Method; Humans; Immunoglobulin G; Immunoglobulin M; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Risk Factors; Smoking; Superoxides; Thiobarbituric Acid Reactive Substances; Vitamin E | 2001 |
Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients.
Topics: Aged; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Cross-Over Studies; Female; Free Radicals; Humans; Kidneys, Artificial; Male; Middle Aged; Oxidative Stress; Pancreatic Elastase; Prospective Studies; Renal Dialysis; Vitamin E | 2001 |
Comparison of a vitamin E-rich diet and supplemental vitamin E on measures of vitamin E status and lipoprotein profile.
Topics: Adult; Aged; Antioxidants; Cardiovascular Diseases; Cholesterol; Diet; Dietary Supplements; Female; Humans; Lipoproteins; Male; Middle Aged; Vitamin E | 2001 |
Oxidative stress and cardiovascular disease in dialyzed patients.
Topics: Aldehydes; Antioxidants; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Reactive Oxygen Species; Reference Values; Renal Dialysis; Vitamin E | 2002 |
Lipid peroxidation, vitamin E, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Epoprostenol; Humans; Lipid Peroxidation; Lipid Peroxides; Vitamin E | 1992 |
Effect of fish oil concentrate on risk factors of cardiovascular complications in renal transplantation.
Topics: Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Erythrocyte Membrane; Fatty Acids; Fish Oils; Humans; Kidney Transplantation; Lipids; Platelet Aggregation; Risk Factors; Transplantation, Homologous; Triglycerides; Vitamin E | 1989 |
Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Netherlands; Prospective Studies; Risk; Selenium; Vitamin A; Vitamin E | 1987 |
232 other study(ies) available for d-alpha tocopherol and Cardiovascular Diseases
Article | Year |
---|---|
Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular modeling studies.
Topics: Animals; Benzoxazoles; Cardiovascular Diseases; Diabetes Complications; Humans; Liver; Models, Molecular; Molecular Docking Simulation; Rats | 2012 |
Alpha-tocopherol exerts protective function against the mucotoxicity of particulate matter in amphibian and human goblet cells.
Topics: Air Pollutants; Air Pollution; alpha-Tocopherol; Animals; Anura; Cardiovascular Diseases; Cell Line, Tumor; Embryo, Nonmammalian; Goblet Cells; Humans; Mucus; Particulate Matter; Protective Agents; Reactive Oxygen Species; Vehicle Emissions | 2020 |
Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.
Topics: alpha-Tocopherol; beta Carotene; Cardiovascular Diseases; Cause of Death; Chromatography, Liquid; Dietary Supplements; Finland; Humans; Male; Metabolomics; Middle Aged; Neoplasms; Prospective Studies; Risk Factors; Tandem Mass Spectrometry | 2018 |
Role of Borage Seed Oil and Fish Oil with or without Turmeric and Alpha- Tocopherol in Prevention of Cardiovascular Disease and Fatty Liver in Rats.
Topics: alpha-Tocopherol; Animals; Antioxidants; Borago; Cardiovascular Diseases; Curcuma; Curcumin; Dietary Supplements; Dyslipidemias; Fatty Acids, Unsaturated; Fatty Liver; Fish Oils; Liver; Male; Metabolic Syndrome; Myocardium; Plant Oils; Rats, Sprague-Dawley; Seeds | 2018 |
Relationship Between Serum Alpha-Tocopherol and Overall and Cause-Specific Mortality.
Topics: Aged; alpha-Tocopherol; Biomarkers; Cardiovascular Diseases; Cause of Death; Cohort Studies; Dietary Supplements; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Prospective Studies | 2019 |
An almond-enriched diet increases plasma α-tocopherol and improves vascular function but does not affect oxidative stress markers or lipid levels.
Topics: Adult; alpha-Tocopherol; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Humans; Male; Middle Aged; Oxidative Stress; Prunus; Risk Factors; Triglycerides; Young Adult | 2014 |
The vitamin E isoforms α-tocopherol and γ-tocopherol have opposite associations with spirometric parameters: the CARDIA study.
Topics: Adolescent; Adult; alpha-Tocopherol; Biomarkers; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Female; Follow-Up Studies; Forced Expiratory Volume; gamma-Tocopherol; Humans; Longitudinal Studies; Male; Risk Factors; Spirometry; Vitamin E; Young Adult | 2014 |
Relation between plasma antioxidant vitamin levels, adiposity and cardio-metabolic profile in adolescents: Effects of a multidisciplinary obesity programme.
Topics: Adiposity; Adolescent; alpha-Tocopherol; Anthropometry; Antioxidants; Apolipoproteins; beta Carotene; Cardiovascular Diseases; Carotenoids; Child; Cholesterol; Cohort Studies; Diet; Female; Follow-Up Studies; Humans; Lycopene; Male; Metabolic Syndrome; Nutrition Assessment; Overweight; Pediatric Obesity; Risk Factors; Triglycerides; Vitamin A; Vitamins | 2017 |
Periplogenin-3-O- -D-glucopyranosyl -(1-->6)- -D-glucopyaranosyl- -(1-->4) -D-cymaropyranoside, isolated from Aegle marmelos protects doxorubicin induced cardiovascular problems and hepatotoxicity in rats.
Topics: Aegle; Alanine Transaminase; alpha-Tocopherol; Animals; Antibiotics, Antineoplastic; Antioxidants; Body Weight; Cardiovascular Diseases; Catalase; Chemical and Drug Induced Liver Injury; Creatine Kinase, MB Form; Digitoxigenin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Glutathione; Lipid Peroxidation; Lipids; Liver Diseases; Plant Leaves; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |
Independent inverse relationship between serum lycopene concentration and arterial stiffness.
Topics: Adult; Aged; alpha-Tocopherol; Arteries; beta Carotene; Cardiovascular Diseases; Carotenoids; Female; Humans; Inflammation; Lipoproteins, LDL; Lycopene; Middle Aged; Oxidative Stress; Oxygen; Regression Analysis | 2010 |
Glutathione s-transferase m1 and t1 polymorphisms and susceptibility to oxidative damage in healthy korean smokers.
Topics: Adult; alpha-Tocopherol; Antioxidants; Cardiovascular Diseases; Cholesterol, HDL; DNA Damage; Genetic Predisposition to Disease; Genotype; Glutathione Peroxidase; Glutathione Transferase; Humans; Korea; Lipid Peroxidation; Lipids; Male; Middle Aged; Oxidative Stress; Polymorphism, Genetic; Smoking | 2010 |
Amelioration of cadmium-induced oxidative stress, impairment in lipids and plasma lipoproteins by the combined treatment with quercetin and α-tocopherol in rats.
Topics: alpha-Tocopherol; Animals; Antioxidants; Cadmium Chloride; Cadmium Poisoning; Cardiovascular Diseases; Dyslipidemias; Environmental Pollutants; Glutathione; Lipid Peroxidation; Liver; Male; Oxidative Stress; Quercetin; Random Allocation; Rats; Rats, Wistar; Risk Factors; Thiobarbituric Acid Reactive Substances | 2010 |
Relation of serum α- and γ-tocopherol levels to cardiovascular disease-related mortality among Japanese men and women.
Topics: Adult; Aged; alpha-Tocopherol; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Follow-Up Studies; gamma-Tocopherol; Humans; Japan; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Distribution | 2012 |
Antioxidants and atherosclerosis: don't throw out the baby with the bath water.
Topics: alpha-Tocopherol; Antioxidants; Arteriosclerosis; Ascorbic Acid; Cardiovascular Diseases; Carotid Artery Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Male; Oxidative Stress; Vitamin E | 2003 |
Influence of alpha-tocopherol upon development of cardiovascular necrosis and hypertension in the rat.
Topics: alpha-Tocopherol; Animals; Cardiovascular Diseases; Hypertension; Necrosis; Rats; Vitamin E | 1954 |
Vitamin C deficiency exerts paradoxical cardiovascular effects in osteogenic disorder Shionogi (ODS) rats.
Topics: Acetylcholine; alpha-Tocopherol; Animals; Aorta; Arrhythmias, Cardiac; Ascorbic Acid; Ascorbic Acid Deficiency; Blood Pressure; Bone Diseases; Cardiovascular Diseases; Diet; Epinephrine; Heart Rate; Male; Muscle Contraction; Myocardial Ischemia; Myocardial Reperfusion; Norepinephrine; Osteogenesis; Phenylephrine; Rats; Rats, Mutant Strains; Rats, Wistar | 2004 |
To "E" or not to "E," vitamin E's role in health and disease is the question.
Topics: alpha-Tocopherol; Animals; Antioxidants; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; gamma-Tocopherol; Humans; Oxidative Stress; Tocotrienols; Vitamin E | 2004 |
Natural alpha-tocopherol in general practice.
Topics: alpha-Tocopherol; Cardiovascular Diseases; Family Practice; General Practice; Humans; Vitamin E | 1950 |
Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Body Mass Index; Cardiovascular Diseases; Cause of Death; Cohort Studies; Diet; Female; Fruit; Humans; Male; Maryland; Middle Aged; Neoplasms; Smoking; Vegetables | 2004 |
The less than dramatic impact on CVD of dietary cholesterol.
Topics: Adult; Aged; alpha-Tocopherol; beta Carotene; Cardiovascular Diseases; Cholesterol, Dietary; Dietary Supplements; Female; Health Surveys; Humans; Male; Middle Aged; Primary Prevention; Risk Factors; Treatment Outcome; United States | 2004 |
Future directions in clinical vitamin E research: panel discussion B.
Topics: alpha-Tocopherol; Animals; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Humans; Isoprostanes; Oxidative Stress; Research; Vitamin E | 2004 |
Low-dose aspirin and vitamin E: challenges and opportunities in cancer prevention.
Topics: alpha-Tocopherol; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Female; Humans; Neoplasms | 2005 |
Vitamin E and cardiovascular health: does sex matter?
Topics: Aged; alpha-Tocopherol; Cardiovascular Diseases; Diet; Exercise; Female; Humans; Male; Middle Aged; Risk; Sex Factors; Vitamin E | 2005 |
Vitamin E supplementation, cardiovascular events, and cancer.
Topics: alpha-Tocopherol; Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Neoplasms; Thiazolidinediones | 2005 |
Vitamin E supplementation, cardiovascular events, and cancer.
Topics: alpha-Tocopherol; Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Neoplasms; Risk; Thiazolidinediones; Vitamin E | 2005 |
Vitamin E supplementation, cardiovascular events, and cancer.
Topics: alpha-Tocopherol; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Dietary Supplements; Humans; Neoplasms; Risk; Vascular Diseases | 2005 |
Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA).
Topics: Aged; Aging; alpha-Tocopherol; Antioxidants; beta Carotene; Body Mass Index; Cardiovascular Diseases; Carotenoids; Cause of Death; Cohort Studies; Confidence Intervals; Europe; Female; Follow-Up Studies; Health Status; Humans; Life Style; Male; Meta-Analysis as Topic; Neoplasms; Nutritional Status; Odds Ratio; Proportional Hazards Models; Prospective Studies | 2005 |
Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Topics: Aged; alpha-Tocopherol; Cardiovascular Diseases; Cause of Death; Chromatography, High Pressure Liquid; Cohort Studies; Confidence Intervals; Diet; Dietary Supplements; Dose-Response Relationship, Drug; Fasting; Finland; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Middle Aged; Mortality; Neoplasms; Odds Ratio; Proportional Hazards Models; Prospective Studies; Smoking; Vitamin E | 2006 |
The relationship between total plasma carotenoids and risk factors for chronic disease among middle-aged and older men.
Topics: Aged; Alcohol Drinking; alpha-Tocopherol; beta Carotene; Cardiovascular Diseases; Carotenoids; Cholesterol; Chronic Disease; Cross-Sectional Studies; Cryptoxanthins; Humans; Life Style; Logistic Models; Lutein; Lycopene; Male; Middle Aged; Risk; Risk Factors; Smoking; Vitamins; Xanthophylls; Zeaxanthins | 2008 |
Supplementation of alpha-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type II diabetic rats.
Topics: alpha-Tocopherol; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; gamma-Tocopherol; Insulin; Male; Mitochondria; Rats; Rats, Long-Evans; Reactive Oxygen Species; Risk Factors; Signal Transduction | 2008 |
Nutrition and metabolism: alpha-tocopherol to prevent cardiovascular disease--deficiency, dose, delivery, and developing context.
Topics: alpha-Tocopherol; Animals; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Nutrition Assessment; Vitamin E Deficiency | 2008 |
USPSTF: Using Vitamins and Minerals to Prevent CVD and Cancer Doesn't Work.
Topics: beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Minerals; Neoplasms; Vitamin A; Vitamin E; Vitamin K; Vitamins | 2022 |
USPSTF recommends against beta carotene or vitamin E supplements for preventing CVD or cancer in adults.
Topics: Adult; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Minerals; Neoplasms; Practice Guidelines as Topic; Vitamin E; Vitamins | 2022 |
Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats.
Topics: Animals; Cardiovascular Diseases; Dipeptides; Disease Models, Animal; Drug Therapy, Combination; Liver; MicroRNAs; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Risk Factors; Vitamin E | 2022 |
Tocotrienols Influence Body Weight Gain and Brain Protein Expression in Long-Term High-Fat Diet-Treated Mice.
Topics: Animals; Antioxidants; Body Weight; Cardiovascular Diseases; Cognition; Cognitive Dysfunction; Diabetes Mellitus; Diet, High-Fat; Hypertension; Male; Mice; Mice, Inbred C57BL; Obesity; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Tocopherols; Tocotrienols; Vitamin E; Weight Gain | 2020 |
[Effects of vitamin E and ω-3 fatty acids on protecting ambient PM_(2. 5)-induced cardiovascular injury].
Topics: Animals; Cardiovascular Diseases; Fatty Acids, Omega-3; Glutathione Peroxidase; Malondialdehyde; Oxidative Stress; Particulate Matter; Protective Agents; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E | 2017 |
Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.
Topics: Aspirin; Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lipoprotein(a); Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Assessment; Risk Factors; Vitamin E; Vitamins; Women's Health | 2018 |
Changes in serum afamin and vitamin E levels after selective LDL apheresis.
Topics: Apolipoprotein A-I; Blood Component Removal; Cardiovascular Diseases; Carrier Proteins; Case-Control Studies; Cholesterol, HDL; Glycoproteins; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Serum Albumin, Human; Tocopherols; Vitamin E | 2018 |
Oxidant-antioxidant status and assessment of cardiovascular morbidity in Pan Masala containing Tobacco users: a cross-sectional study.
Topics: Adult; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Male; Malondialdehyde; Middle Aged; Nepal; Oxidative Stress; Tobacco, Smokeless; Vitamin E | 2018 |
Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Topics: Analysis of Variance; Antioxidants; Cardiovascular Diseases; Chromans; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Postmenopause; Probucol; Progestins; Quercetin; Resveratrol; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamin E; Wine | 2018 |
Dietary Intake of Anti-Oxidant Vitamins A, C, and E Is Inversely Associated with Adverse Cardiovascular Outcomes in Chinese-A 22-Years Population-Based Prospective Study.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Asian People; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cardiovascular System; Cholesterol; Diet; Dietary Fiber; Female; Follow-Up Studies; Hong Kong; Humans; Male; Middle Aged; Potassium; Prevalence; Proportional Hazards Models; Prospective Studies; Risk Factors; Sodium; Triglycerides; Vitamin A; Vitamin E; Waist Circumference | 2018 |
Association Between Fat-soluble Vitamins and Lipid Profile in the Overweight Population.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Cross-Sectional Studies; Female; Humans; Lipids; Male; Middle Aged; Obesity; Overweight; Patents as Topic; Proprotein Convertase 9; Triglycerides; Vitamin A; Vitamin D; Vitamin E; Vitamin E Deficiency | 2020 |
Vitamins - wrong approaches.
Topics: Antioxidants; Ascorbic Acid; Avitaminosis; beta Carotene; Cardiovascular Diseases; Chronic Disease; Dietary Supplements; Dose-Response Relationship, Drug; Female; Humans; Male; Nutrition Policy; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E; Vitamins | 2012 |
Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy.
Topics: Age Factors; Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Cardiac Output; Cardiovascular Diseases; Dexamethasone; Heart Rate; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Ventricular Remodeling; Vitamin E; Vitamins | 2013 |
Steroids and antioxidants: a neonatal cocktail for saving your adult heart?
Topics: Animals; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Dexamethasone; Male; Vitamin E; Vitamins | 2013 |
Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement.
Topics: Adult; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Middle Aged; Minerals; Neoplasms; Primary Prevention; Research; Risk Assessment; Vitamin E; Vitamins | 2014 |
Summaries for patients. Vitamin, mineral, and multivitamin supplements to prevent cardiovascular disease and cancer: recommendations from the U.S. Preventive Services Task Force.
Topics: Adult; beta Carotene; Cardiovascular Diseases; Dietary Supplements; Humans; Minerals; Neoplasms; Primary Prevention; Risk Assessment; Vitamin E; Vitamins | 2014 |
Combined neonatal therapies for cardiac function in adulthood - live together, die alone?
Topics: Animals; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Dexamethasone; Male; Vitamin E; Vitamins | 2014 |
Massive and long-lasting decrease in vitamin C plasma levels as a consequence of extracorporeal circulation.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Cardiopulmonary Bypass; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Dehydroascorbic Acid; Electron Spin Resonance Spectroscopy; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Time Factors; Vitamin E | 2014 |
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome.
Topics: Adult; Anthropometry; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Cushing Syndrome; Female; Glucose; Hormones; Humans; Isoprostanes; Male; Middle Aged; Oxidants; Oxidative Stress; Platelet Activation; Thromboxane B2; Vitamin E | 2015 |
Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease.
Topics: Amino Acid Substitution; Aspirin; Cardiovascular Diseases; Catechol O-Methyltransferase; Female; Follow-Up Studies; Genome-Wide Association Study; Humans; Incidence; Meta-Analysis as Topic; Middle Aged; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 2014 |
Multivitamins to ward off CVD and cancer: yay or nay?
Topics: Attitude to Health; Cardiovascular Diseases; Dietary Supplements; Female; Health Behavior; Humans; Male; Middle Aged; Neoplasms; Primary Prevention; United States; Vitamin B Complex; Vitamin E; Vitamins | 2014 |
Antioxidant vitamin intake and mortality in three Central and Eastern European urban populations: the HAPIEE study.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cause of Death; Czech Republic; Dietary Supplements; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Poland; Proportional Hazards Models; Prospective Studies; Risk Factors; Russia; Socioeconomic Factors; Surveys and Questionnaires; Urban Population; Vitamin E; Vitamins | 2016 |
Protective effect of vitamin E against diabetes-induced oxidized LDL and aorta cell wall proliferation in rat.
Topics: Animals; Antioxidants; Aorta; C-Reactive Protein; Cardiovascular Diseases; Cell Proliferation; Diabetes Mellitus; Hyperlipidemias; Lipids; Lipoproteins, LDL; Male; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Wistar; Vitamin E | 2015 |
Habitual dietary intake of β-carotene, vitamin C, folate, or vitamin E may interact with single nucleotide polymorphisms on brachial-ankle pulse wave velocity in healthy adults.
Topics: Alleles; Ankle Brachial Index; Ascorbic Acid; beta Carotene; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Diet; Female; Folic Acid; Gene-Environment Interaction; Genotype; Humans; Male; Middle Aged; Nutrition Assessment; Polymorphism, Single Nucleotide; Republic of Korea; Risk Factors; Rural Population; Vascular Stiffness; Vitamin E | 2016 |
Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation.
Topics: Administration, Oral; Animals; Antioxidants; Aorta; Ascorbic Acid; Cardiovascular Diseases; Cardiovascular System; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Fruit; Glutathione; Glutathione Peroxidase; Hypertension; Lipid Peroxidation; Lipid Peroxides; Male; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vanillic Acid; Vascular Remodeling; Vegetables; Vitamin E | 2015 |
Complement and Cardiovascular Disease--The Missing Link in Haemodialysis Patients.
Topics: Aged; Cardiovascular Diseases; Complement C3; Complement Factor D; Complement Factor H; Complement Membrane Attack Complex; Complement System Proteins; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Membranes, Artificial; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors; Vitamin E | 2016 |
Combined effects of vitamin E and omega-3 fatty acids on protecting ambient PM
Topics: Air Pollutants; Animals; Antioxidants; Cardiovascular Diseases; Cytokines; Drug Therapy, Combination; Fatty Acids, Omega-3; Glutathione Peroxidase; Inflammation; Interleukin-6; Male; Malondialdehyde; Oxidative Stress; Particulate Matter; Protective Agents; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Vitamin E | 2017 |
Dietary antioxidant vitamins intake and mortality: A report from two cohort studies of Chinese adults in Shanghai.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Asian People; Cardiovascular Diseases; Carotenoids; Cause of Death; China; Cohort Studies; Diet; Dietary Supplements; Dose-Response Relationship, Drug; Female; Humans; Male; Neoplasms; Proportional Hazards Models; Prospective Studies; Risk Factors; Socioeconomic Factors; Surveys and Questionnaires; Vitamin E; Vitamins | 2017 |
The Influence of Dietary Components on Early Signs of Atherosclerosis in Apparently Healthy Young-adult Males: An Observational Study of 615 Subjects.
Topics: Adult; Age Factors; Antioxidants; Atherosclerosis; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-Sectional Studies; Diet; Diet, Healthy; Energy Intake; Humans; Male; Middle Aged; Risk Factors; Surveys and Questionnaires; Vitamin E; Waist Circumference | 2017 |
Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress.
Topics: Advanced Oxidation Protein Products; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cytokines; Female; Humans; Inflammation Mediators; Male; Malondialdehyde; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Renal Insufficiency, Chronic; Superoxide Dismutase; Vitamin E | 2017 |
Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
Topics: Adjuvants, Pharmaceutic; Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Insulin; Insulin Resistance; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Vitamin E | 2008 |
Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease.
Topics: Aged; Aspirin; Cardiovascular Diseases; Female; Genetic Predisposition to Disease; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Migraine Disorders; Neoplasms; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
I've read articles that both praised antioxidant supplements, such as vitamin E, and also suggested that they may be extremely harmful. Can you shed some light on this controversy and suggest safe ways to improve antioxidant levels in our bodies?
Topics: Antioxidants; Cardiovascular Diseases; Humans; Risk Factors; Vitamin E | 2008 |
Nutrition and metabolism: vitamin E to prevent cardiovascular disease: parts, partners, persons, processing, and patterns.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Vitamin E | 2008 |
Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women.
Topics: Aged; Aspirin; Biomarkers; Cardiovascular Diseases; Carotenoids; Cross-Sectional Studies; Female; Fruit; Humans; Life Style; Lipids; Lycopene; Middle Aged; Neoplasms; Risk Factors; Vegetables; Vitamin E; Women's Health | 2008 |
The influence of vitamin E on vascular disease.
Topics: Cardiovascular Diseases; Humans; Vascular Diseases; Vitamin E; Vitamins | 1948 |
Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role?
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Dietary Supplements; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Vitamin E | 2009 |
[Vitamins E and C in the prevention of cardiovascular disease in men. The physicians' health study II randomized controlled trial].
Topics: Ascorbic Acid; Cardiovascular Diseases; Humans; Male; Randomized Controlled Trials as Topic; Vitamin E | 2009 |
Vitamins E and C in the prevention of cardiovascular disease and cancer in men.
Topics: Aged; Ascorbic Acid; Cardiovascular Diseases; Clinical Protocols; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Male; Middle Aged; Neoplasms; Oxidative Stress; Patient Compliance; Prostatic Neoplasms; Vitamin E | 2009 |
Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good.
Topics: Adult; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Computer Simulation; Decision Support Techniques; Evidence-Based Medicine; Female; Humans; Male; Markov Chains; Meta-Analysis as Topic; Middle Aged; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vitamin E | 2009 |
Antioxidant supplements and cardiovascular disease in men.
Topics: Antioxidants; Ascorbic Acid; Biological Availability; Cardiovascular Diseases; Dietary Supplements; Humans; Male; Vitamin E; Vitamins | 2009 |
Antioxidant supplements and cardiovascular disease in men.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Dietary Supplements; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Vitamin E; Vitamins | 2009 |
[Relationship between serum lipids and status of vitamin C and E as antioxidants in Venezuelan elderly people].
Topics: Aged; Aged, 80 and over; Aging; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Epidemiologic Methods; Female; Humans; Lipids; Male; Middle Aged; Nutritional Status; Sex Distribution; Sex Factors; Triglycerides; Venezuela; Vitamin E | 2008 |
Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.
Topics: Aspirin; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Fasting; Female; Humans; Hypercholesterolemia; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Statistics, Nonparametric; Triglycerides; Vitamin E | 2009 |
Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Dietary Supplements; Genetic Predisposition to Disease; Haptoglobins; Humans; Oxidative Stress; Patient Selection; Randomized Controlled Trials as Topic; Vitamin E | 2009 |
Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality.
Topics: Aged; Ascorbic Acid; Cardiovascular Diseases; Cohort Studies; Dietary Supplements; Follow-Up Studies; Humans; Middle Aged; Mortality; Neoplasms; Proportional Hazards Models; Vitamin E; Vitamins; Washington | 2009 |
Effects of kiwifruit consumption on serum lipid profiles and antioxidative status in hyperlipidemic subjects.
Topics: Actinidia; Adult; Aged; Aldehydes; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Cholesterol; Female; Fruit; Humans; Hyperlipidemias; Lipid Peroxidation; Lipids; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Risk Factors; Time Factors; Vitamin E; Young Adult | 2009 |
Investigation of the use of antioxidants to diminish the adverse effects of postnatal glucocorticoid treatment on mortality and cardiac development.
Topics: Aldehydes; Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Chronic Disease; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Heart; HSP90 Heat-Shock Proteins; Lung Diseases; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Vitamin E | 2010 |
Effects of a flavonol-rich diet on select cardiovascular parameters in a Golden Syrian hamster model.
Topics: Abdominal Fat; Animals; Antioxidants; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Cricetinae; Diet; Dietary Fats; Disease Models, Animal; Drug Therapy, Combination; Flavonols; Heart Rate; Hypercholesterolemia; Mesocricetus; Phytotherapy; Plant Preparations; Powders; Rutin; Vaccinium macrocarpon; Vitamin E | 2010 |
Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats.
Topics: Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Body Weight; Cardiovascular Diseases; Dexamethasone; Dose-Response Relationship, Drug; Female; Femoral Artery; Glucocorticoids; In Vitro Techniques; Male; Nitric Oxide Donors; Nitroprusside; Peritonitis; Potassium; Random Allocation; Rats; Rats, Wistar; Survival Rate; Time Factors; Vasoconstriction; Vitamin E | 2010 |
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Haptoglobins; Humans; Phenotype; Vitamin E | 2010 |
Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Genotype; Haptoglobins; Humans; Myocardial Infarction; Stroke; Tocopherols; Vitamin E | 2010 |
How to avoid a heart attack: putting it all together.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Humans; Myocardial Infarction; Vitamin B Complex; Vitamin E | 2010 |
Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease.
Topics: Cardiovascular Diseases; Fatty Liver; Humans; Randomized Controlled Trials as Topic; Vitamin E | 2010 |
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Topics: Antioxidants; Cardiovascular Diseases; Dose-Response Relationship, Drug; Fatty Liver; Humans; Meta-Analysis as Topic; Vitamin E | 2010 |
Effect of antioxidant vitamins on the plasma homocysteine level in a free-living elderly population.
Topics: Aged; Aging; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Germany; Glomerular Filtration Rate; Homocysteine; Humans; Longitudinal Studies; Male; Vitamin E; Vitamins | 2010 |
Treatment with Vitamin E-coated membrane dialysers and cardiovascular protection in dialysis patients.
Topics: Antioxidants; Cardiovascular Diseases; Coated Materials, Biocompatible; Humans; Membranes, Artificial; Oxidative Stress; Renal Dialysis; Treatment Outcome; Vitamin E | 2011 |
Evaluation of dietary habits and assessment of cardiovascular disease risk factors among Greek university students.
Topics: American Heart Association; Cardiovascular Diseases; Cholesterol, Dietary; Diet; Dietary Fats; Dietary Fiber; Energy Intake; Feeding Behavior; Female; Folic Acid; Greece; Guidelines as Topic; Humans; Male; Nutrition Policy; Risk Factors; Sodium, Dietary; United States; Vitamin E; White People; Young Adult | 2011 |
Dietary selenium (Se) and vitamin E (V(E)) supplementation modulated methylmercury-mediated changes in markers of cardiovascular diseases in rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Male; Methylmercury Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Selenium; Vitamin E | 2012 |
Concordance of randomized and nonrandomized studies was unrelated to translational patterns of two nutrient-disease associations.
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Data Interpretation, Statistical; Docosahexaenoic Acids; Eicosapentaenoic Acid; Evidence-Based Medicine; Fatty Acids, Omega-3; Food; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Translational Research, Biomedical; Treatment Outcome; Vitamin E | 2012 |
Mediterranean Diet Effect: an Italian picture.
Topics: Adult; Antioxidants; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Carotenoids; Cholesterol; Diet, Mediterranean; Feeding Behavior; Female; Humans; Interleukin-10; Interviews as Topic; Italy; Lipid Peroxidation; Male; Malondialdehyde; Nutritional Status; Oxidative Stress; Risk Factors; Surveys and Questionnaires; Triglycerides; Tumor Necrosis Factor-alpha; Vitamin A; Vitamin E; Vitamins; Young Adult | 2011 |
Vitamin A, E, B12, and folic acid in end-stage renal disease Tunisian patients: status and predictive value for overall mortality and cardiovascular events.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Cause of Death; Comorbidity; Female; Folic Acid; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Smoking; Tunisia; Vitamin A; Vitamin B 12; Vitamin E; Young Adult | 2011 |
Dietary intakes of zinc and heme iron from red meat, but not from other sources, are associated with greater risk of metabolic syndrome and cardiovascular disease.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Eating; Female; Heme; Humans; Iron, Dietary; Male; Meat; Metabolic Syndrome; Micronutrients; Middle Aged; Prospective Studies; Risk Factors; Vitamin E; Zinc | 2012 |
[Peculiarities of vitamin status in men and women with cardiovascular disease and obesity].
Topics: Aged; Ascorbic Acid; beta Carotene; Body Mass Index; Cardiovascular Diseases; Diet; Female; Humans; Male; Meals; Middle Aged; Obesity; Riboflavin; Sex Factors; Vitamin B 6; Vitamin E; Vitamins | 2012 |
The quality of the nutrition in smokers.
Topics: Adult; Ascorbic Acid; Calcium, Dietary; Cardiovascular Diseases; Czech Republic; Dietary Fats; Dietary Proteins; Feeding Behavior; Female; Humans; Iron, Dietary; Male; Middle Aged; Neoplasms; Nutrition Surveys; Risk Factors; Smoking; Vitamin E | 2012 |
Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation.
Topics: Aged; Analysis of Variance; Ascorbic Acid; Cardiovascular Diseases; Case-Control Studies; Dietary Supplements; Female; Follow-Up Studies; Glutathione Peroxidase; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Reference Values; Retrospective Studies; Risk Assessment; Superoxide Dismutase; Treatment Outcome; Vitamin E | 2013 |
The Boyd Orr lecture. Nutrition interventions in aging and age-associated disease.
Topics: Activities of Daily Living; Aged; Aging; Antioxidants; Cardiovascular Diseases; Chronic Disease; Cognition Disorders; Energy Intake; Fruit; Humans; Neoplasms; Nutrition Disorders; Nutritional Requirements; Nutritional Status; Oxidative Stress; Risk Factors; Vegetables; Vitamin E | 2002 |
Fruit and vegetable intake and chronic disease risk in Portugal.
Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Carotenoids; Female; Folic Acid; Fruit; Homocysteine; Humans; Male; Middle Aged; Morbidity; Neoplasms; Portugal; Risk Factors; Surveys and Questionnaires; Vegetables; Vitamin B 12; Vitamin B 6; Vitamin E | 2002 |
[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].
Topics: Cardiovascular Diseases; Diet; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Triglycerides; Vitamin E | 1999 |
Plasma vitamin E, total antioxidant status and vascular function in young adults.
Topics: Adult; Antioxidants; Brachial Artery; Cardiovascular Diseases; Elasticity; Endothelium, Vascular; Female; Humans; Male; Muscle, Smooth, Vascular; Regional Blood Flow; Regression Analysis; Risk Assessment; Ultrasonography; Vitamin E | 2002 |
Vitamin C protects low-density lipoprotein from homocysteine-mediated oxidation.
Topics: Ascorbic Acid; Cardiovascular Diseases; Copper; Dehydroascorbic Acid; Dose-Response Relationship, Drug; Free Radicals; Homocysteine; Humans; Iron; Lipoproteins; Lipoproteins, LDL; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Temperature; Thiobarbituric Acid Reactive Substances; Time Factors; Vitamin E | 2003 |
n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans.
Topics: Adult; Animals; Antioxidants; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Fatty Acids, Omega-3; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Middle Aged; Milk; Oleic Acid; Oxidation-Reduction; Risk Factors; Vascular Cell Adhesion Molecule-1; Vitamin B 6; Vitamin E | 2003 |
Free radical disease prevention and nutrition.
Topics: Adult; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Diet; Diet, Vegetarian; Female; Free Radicals; Homocysteine; Humans; Male; Middle Aged; Random Allocation; Trace Elements; Vitamin E | 2003 |
[Prophylaxis of vascular diseases].
Topics: Cardiovascular Diseases; Heparin; Humans; Prothrombin Time; Thromboembolism; Vascular Diseases; Vitamin E | 1953 |
A means of lowering elevated blood cholesterol levels in patients with previous myocardial infarction.
Topics: Cardiovascular Diseases; Cholesterol; Fatty Acids; Humans; Myocardial Infarction; Steroids; Vitamin B 6; Vitamin E | 1958 |
Antioxidant vitamins for prevention of cardiovascular disease.
Topics: Antioxidants; beta Carotene; Cardiovascular Diseases; Contraindications; Female; Humans; Male; Meta-Analysis as Topic; Treatment Outcome; Vitamin E; Vitamins | 2003 |
[On combined vitamin A, B-6 and E therapy of arteriosclerotic peripheral blood circulation disorders and its angiomyographic control].
Topics: Cardiovascular Diseases; Hematologic Diseases; Peripheral Vascular Diseases; Physiological Phenomena; Vascular Diseases; Vitamin A; Vitamin B 6; Vitamin E | 1960 |
Antioxidant vitamins do not prevent cardiovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; beta Carotene; Cardiovascular Diseases; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Survival Rate; Treatment Outcome; Vitamin E | 2003 |
Childhood and adult dietary vitamin E intake and cardiovascular risk factors in mid-life in the 1946 British Birth Cohort.
Topics: Adult; Antioxidants; Body Composition; Body Constitution; Cardiovascular Diseases; Child Development; Child, Preschool; Cohort Studies; Confidence Intervals; Female; Humans; Hypertension; Longitudinal Studies; Male; Mental Recall; Odds Ratio; Risk Factors; Social Class; United Kingdom; Vitamin E | 2003 |
[Association of tocopherol, diethylstilbene in cardiovascular therapy].
Topics: Cardiovascular Diseases; Humans; Stilbenes; Tocopherols; Vitamin E | 1950 |
Vitamin E in the treatment of cardiovascular-renal diseases.
Topics: Cardiovascular Diseases; Humans; Hypertension, Renal; Kidney; Nephritis; Vitamin E | 1951 |
[Vitamin E in therapy of circulatory disorders, Dupuytren's contracture and thromboses].
Topics: Cardiovascular Diseases; Dupuytren Contracture; Humans; Peripheral Vascular Diseases; Thrombosis; Vascular Diseases; Vitamin E | 1951 |
Effect of supplemental antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Coenzymes; Dietary Supplements; Humans; Ubiquinone; Vitamin E | 2003 |
The role of antioxidant therapy in cardiovascular disease.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Endarterectomy; Humans; Oxidative Stress; Treatment Outcome; Vitamin E | 2004 |
Designer eggs: best way to get your omega-3 fatty acids?
Topics: Cardiovascular Diseases; Docosahexaenoic Acids; Eggs; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Pregnancy; Seafood; Vitamin E | 2004 |
Health effect of vegetable-based diet: lettuce consumption improves cholesterol metabolism and antioxidant status in the rat.
Topics: Animals; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet; Feces; Lactuca; Lipid Peroxidation; Liver; Male; Postprandial Period; Random Allocation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Vitamin E | 2004 |
Lyophilized carrot ingestion lowers lipemia and beneficially affects cholesterol metabolism in cholesterol-fed C57BL/6J mice.
Topics: Animals; Antioxidants; Bile Acids and Salts; Cardiovascular Diseases; Cholesterol; Daucus carota; Fatty Acids, Volatile; Feces; Freeze Drying; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Random Allocation; Sterols; Triglycerides; Vitamin E | 2004 |
[Critical revision and pathogenic interpretation of vitamin E therapy].
Topics: Cardiovascular Diseases; Diabetes Mellitus; Hematopoietic System; Humans; Liver; Vitamin E | 1950 |
The influence of vitamin E on cardiovascular disorders.
Topics: Cardiovascular Diseases; Humans; Leadership; Vitamin E | 1950 |
[Vitamin E in the treatment of cardiovascular disease].
Topics: Cardiovascular Diseases; Humans; Vitamin E | 1950 |
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Topics: Alleles; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Haptoglobins; Humans; Phenotype; Vitamin E | 2004 |
Unique technology for solubilization and delivery of highly lipophilic bioactive molecules.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Erythrocytes; Hemolysis; Humans; Hydrolysis; Jurkat Cells; Lipids; Male; Molecular Weight; Pharmaceutical Preparations; Pharmacokinetics; Polyenes; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sterols; Vitamin E | 2004 |
The level of evidence for permitting a qualified health claim: FDA's review of the evidence for selenium and cancer and vitamin E and heart disease.
Topics: Cardiovascular Diseases; Heart Diseases; Neoplasms; Reproducibility of Results; Selenium; United States; United States Food and Drug Administration; Vitamin E | 2005 |
Future directions in preclinical vitamin E research: panel discussion A.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Research; Vitamin E; Vitamin E Deficiency | 2004 |
Is there any hope for vitamin E?
Topics: Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Neoplasms; Risk; Vitamin E | 2005 |
Dietary vitamin A may be a cardiovascular risk factor in a Saudi population.
Topics: Antioxidants; Ascorbic Acid; Body Mass Index; Cardiovascular Diseases; Carotenoids; Case-Control Studies; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mellitus; Dietary Fats; Humans; Hypertension; Lipid Peroxidation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prevalence; Risk Factors; Saudi Arabia; Smoking; Surveys and Questionnaires; Vitamin A; Vitamin E | 2005 |
An editorial update: Annus horribilis for vitamin E.
Topics: Cardiovascular Diseases; Dietary Supplements; Humans; Mortality; Neoplasms; Neurodegenerative Diseases; United States; Vitamin E | 2005 |
New findings about vitamin E: no longer a silver bullet. Supplement does not prevent cancer or major cardio events, as previously believed.
Topics: Antioxidants; Cardiac Output, Low; Cardiovascular Diseases; Heart Failure; Humans; Neoplasms; Vitamin E | 2005 |
High-dose vitamin E supplements get an F.
Topics: Cardiovascular Diseases; Humans; Treatment Failure; Vitamin E | 2005 |
Women's study finds vitamin E, aspirin not so helpful.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Female; Humans; Middle Aged; Neoplasms; Treatment Failure; Vitamin E | 2005 |
Women's health research: evidence from two major trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cardiovascular Diseases; Female; Humans; Neoplasms; Randomized Controlled Trials as Topic; Vitamin E; Women's Health | 2005 |
Role of vitamin E in the prevention of cardiovascular disease and cancer.
Topics: Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Neoplasms; Randomized Controlled Trials as Topic; Vitamin E | 2005 |
Clarifying the evidence: vitamin E, vitamin A, and folate.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Humans; Vitamin A; Vitamin E | 2005 |
Vitamin E. Assessing the risks and benefits.
Topics: Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Neoplasms; Vitamin E | 2006 |
Statins and antioxidant vitamins: should co-administration be avoided?
Topics: Antioxidants; Ascorbic Acid; Atorvastatin; Calcinosis; Cardiovascular Diseases; Coronary Disease; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Vitamin E | 2006 |
Entire potato consumption improves lipid metabolism and antioxidant status in cholesterol-fed rat.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Diet; Dietary Fiber; Fermentation; Humans; Lipid Metabolism; Liver; Male; Organ Size; Postprandial Period; Random Allocation; Rats; Rats, Wistar; Solanum tuberosum; Thiobarbituric Acid Reactive Substances; Triglycerides; Vitamin E | 2006 |
Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Ascorbic Acid; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Delayed Graft Function; Diabetes Complications; Female; Fluorometry; Forearm; Glycated Hemoglobin; Glycation End Products, Advanced; Histocompatibility; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Leg; Linear Models; Male; Middle Aged; Obesity; Risk Factors; Skin; Smoking; Vitamin E | 2006 |
Folate supplementation and cardiovascular disease.
Topics: Antioxidants; Cardiovascular Diseases; Female; Folic Acid; Hematinics; Humans; Randomized Controlled Trials as Topic; Vitamin E | 2006 |
The cardiovascular patient's perceptions of complementary and alternative medicine.
Topics: Aged; Ascorbic Acid; Cardiology; Cardiovascular Diseases; Cohort Studies; Complementary Therapies; Dietary Supplements; Estrogen Replacement Therapy; Female; Humans; Male; Outpatients; Patient Acceptance of Health Care; Phytotherapy; Plants, Medicinal; Surveys and Questionnaires; Texas; Vitamin E | 2006 |
Does vitamin E help prevent heart disease or heart attack?
Topics: Cardiovascular Diseases; Female; Hemorrhage; Humans; Myocardial Infarction; Vitamin E; Vitamins | 2006 |
[Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Topics: Adult; Antioxidants; Cardiovascular Diseases; Case-Control Studies; Copper; Female; Glutathione Peroxidase; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Risk Assessment; Selenium; Superoxide Dismutase; Tunisia; Vitamin A; Vitamin E; Zinc | 2006 |
Are we over oxidized? Oxidative stress, cardiovascular disease, and the future of intervention studies with antioxidants.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Humans; Lipid Peroxidation; Oxidative Stress; Reactive Oxygen Species; Research Design; Ubiquinone; Vitamin E | 2005 |
Comparative study of the effect of tocotrienols and -tocopherol on fasting serum lipid profiles in patients with mild hypercholesterolaemia: a preliminary report.
Topics: Cardiovascular Diseases; Fasting; Humans; Hypercholesterolemia; Lipids; Nigeria; Risk Factors; Tocopherols; Tocotrienols; Vitamin E | 2007 |
Vitamin E to prevent cardiovascular disease: pill or dietary package?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diet; Dietary Supplements; Humans; Hyperlipidemias; Tablets; Vitamin E | 2007 |
The 'vitamin E regeneration system' (VERS) and an algorithm to justify antioxidant supplementation in diabetes--a hypothesis.
Topics: Algorithms; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Dietary Supplements; Free Radicals; Glutathione; Humans; Lipid Peroxidation; Models, Biological; Models, Chemical; Models, Theoretical; Oxidative Stress; Oxygen; Vitamin E | 2008 |
Studies with vitamin E and beta-carotene as single agents do not prove lack of benefit.
Topics: beta Carotene; Cardiovascular Diseases; Diet; Humans; Neoplasms; Vitamin E | 2007 |
Negative results of tocopherol therapy in cardiovascular disease.
Topics: Cardiovascular Diseases; Tocopherols; Vitamin E | 1949 |
The physiological and biochemical basis for the use of vitamin E in cardiovascular disease.
Topics: Cardiovascular Diseases; Humans; Vitamin E | 1949 |
Potential clinical applications for high-dose nutritional antioxidants.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis; Ascorbic Acid; Cardiovascular Diseases; Diabetes Mellitus; Free Radicals; Humans; Hypoxia; Ischemia; Mice; Neoplasms; Rabbits; Rats; Selenium; Superoxides; Thrombosis; Vitamin E | 1984 |
Nutrition for the practitioner IV. Current concepts in nutrition: vitamin E.
Topics: Cardiovascular Diseases; Humans; Infant, Newborn; Nutritional Requirements; Vitamin E; Vitamin E Deficiency | 1984 |
Effects of the type of dietary fat at two levels of vitamin E in Wistar male rats during development and aging. I. Life span, serum biochemical parameters and pathological changes.
Topics: Aging; Animals; Body Weight; Cardiovascular Diseases; Central Nervous System Diseases; Cholesterol; Dietary Fats; Digestive System Diseases; Energy Intake; Eye Diseases; Life Expectancy; Male; Neoplasms; Organ Size; Phospholipids; Rats; Respiratory System; Serum Albumin; Skin Diseases; Tissue Distribution; Triglycerides; Urogenital System; Vitamin E | 1980 |
Antioxidants and cardiovascular disease: why do we still not have the answers?
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; Humans; Vitamin E | 1995 |
Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
Topics: Aged; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Clinical Protocols; Contraindications; Diabetes Complications; Disease Progression; Epidemiologic Methods; Family Practice; Feasibility Studies; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Patient Selection; Primary Prevention; Risk Factors; Thrombosis; Vitamin E | 1995 |
[Antioxidants and cardiovascular disorders--epidemiologic aspects. Should high risk patients receive supplementation?].
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Case-Control Studies; Cohort Studies; Female; Humans; Male; Norway; Prospective Studies; Risk Factors; Vitamin E | 1995 |
Vitamin E.
Topics: Cardiovascular Diseases; Controlled Clinical Trials as Topic; Humans; Intermittent Claudication; Vitamin E | 1995 |
Antioxidant nutrients--do they have a protective role?
Topics: Aged; Aging; Animals; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Carotenoids; DNA Damage; Female; Humans; Male; Middle Aged; Neoplasms; Reactive Oxygen Species; Selenium; Vitamin E | 1994 |
[Essential antioxidants in cardiovascular diseases--lessons for Europe].
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Ethnicity; Europe; Humans; Predictive Value of Tests; Risk Factors; Vitamin E | 1994 |
Antioxidant vitamins--benefits not yet proved.
Topics: Antioxidants; beta Carotene; Cardiovascular Diseases; Carotenoids; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vitamin E | 1994 |
Dietary supplements reduce cancer deaths in China.
Topics: Adult; beta Carotene; Cardiovascular Diseases; Carotenoids; China; Chronic Disease; Deficiency Diseases; Diet; Humans; Neoplasms; Selenium; Vitamin E | 1993 |
Comparison of taurine, alpha-tocopherol, retinol, selenium, and total triglycerides and cholesterol concentrations in cats with cardiac disease and in healthy cats.
Topics: Animals; Cardiomyopathy, Dilated; Cardiovascular Diseases; Cat Diseases; Cats; Cholesterol; Female; Hyperthyroidism; Hypertrophy, Left Ventricular; Male; Reference Values; Selenium; Sex Factors; Taurine; Triglycerides; Vitamin A; Vitamin E | 1993 |
Antioxidant vitamins, cancer, and cardiovascular disease.
Topics: Antioxidants; beta Carotene; Cardiovascular Diseases; Carotenoids; Female; Humans; Male; Neoplasms; Vitamin E | 1996 |
In vitro effects of a flavonoid-rich extract on LDL oxidation.
Topics: Antioxidants; Butylated Hydroxytoluene; Cardiovascular Diseases; Copper; Edetic Acid; Flavonoids; Humans; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Plant Extracts; Plants, Medicinal; Thiobarbituric Acid Reactive Substances; Vitamin E | 1996 |
Vitamin E and exercise in the Northern Ireland population.
Topics: Adolescent; Adult; Aged; Ascorbic Acid; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Exercise; Female; Humans; Linear Models; Lipids; Logistic Models; Male; Middle Aged; Northern Ireland; Physical Fitness; Population Surveillance; Risk Factors; Vitamin E | 1996 |
Antioxidant vitamins: getting to the heart of the matter.
Topics: Antineoplastic Agents; Antioxidants; beta Carotene; Cardiovascular Agents; Cardiovascular Diseases; Carotenoids; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Neoplasms; Vitamin E | 1996 |
Beta-carotene and lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; beta Carotene; Cardiovascular Diseases; Contraindications; Humans; Leukoplakia, Oral; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin A; Vitamin E | 1996 |
Susceptibility of VLDL to oxidation in patients on regular haemodialysis.
Topics: Adult; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Lipoproteins, VLDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Renal Dialysis; Vitamin E | 1997 |
Health and dietary characteristics of supplement users in an elderly population.
Topics: Aged; Aged, 80 and over; Aging; Alcohol Drinking; Ascorbic Acid; Caffeine; Calcium, Dietary; Cardiovascular Diseases; Cohort Studies; Diet; Dietary Fats; Dietary Proteins; Exercise; Female; Food, Fortified; Georgia; Health Status; Humans; Male; Minerals; Neoplasms; Risk Factors; Surveys and Questionnaires; Vitamin E; Vitamins | 1997 |
Vitamin E and cardiovascular protection in diabetes.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Complications; Humans; Vitamin E | 1997 |
Plasma lipid peroxide and antioxidant levels in diabetic patients.
Topics: Adult; Aged; Antioxidants; Arteriosclerosis; Ascorbic Acid; Cardiovascular Diseases; Catalase; Diabetes Mellitus; Female; Glutathione Peroxidase; Humans; Hyperlipidemias; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Vitamin E | 1997 |
Metabolic and antioxidant markers in the plasma of sportsmen from a Mediterranean town performing non-agonistic activity.
Topics: Adult; Age Factors; Antioxidants; Bicycling; Cardiovascular Diseases; Cholesterol, HDL; Coenzymes; Exercise Test; Humans; Italy; Male; Middle Aged; Oxygen Consumption; Risk Factors; Running; Sports; Triglycerides; Ubiquinone; Vitamin E | 1997 |
Antioxidant defense: vitamins E and C and carotenoids.
Topics: Animals; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Diabetic Nephropathies; Diabetic Retinopathy; Diet; Humans; Reactive Oxygen Species; Vitamin E | 1997 |
Contempo 1997: family medicine.
Topics: Antioxidants; Cardiovascular Diseases; Contraindications; Humans; Risk; Vitamin E | 1997 |
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Cyclooxygenase Inhibitors; Dinoprost; Female; Humans; Hypercholesterolemia; Isoindoles; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Phenylbutyrates; Platelet Activation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thromboxane B2; Vitamin E | 1997 |
Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France).
Topics: Aged; Aging; Antioxidants; Blood Pressure; Cardiovascular Diseases; Carotenoids; Chronic Disease; Diabetes Mellitus; Female; Follow-Up Studies; France; Humans; Infant, Newborn; Lipid Peroxidation; Lipids; Longitudinal Studies; Male; Micronutrients; Middle Aged; Oxidation-Reduction; Prevalence; Selenium; Vitamin E | 1997 |
Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study.
Topics: Aged; Antioxidants; Cardiovascular Diseases; Carotenoids; Cross-Sectional Studies; Erythrocytes; Female; France; Humans; Hypolipidemic Agents; Life Style; Lipids; Longitudinal Studies; Male; Middle Aged; Nutritional Status; Regression Analysis; Risk Factors; Selenium; Sex Factors; Smoking; Socioeconomic Factors; Thiobarbituric Acid Reactive Substances; Vitamin E | 1998 |
Exercise and cardiovascular disease: a new perspective.
Topics: Adolescent; Adult; Cardiovascular Diseases; Copper; Exercise; Female; Humans; Lipid Peroxides; Lipoproteins, LDL; Male; Oxidative Stress; Oxygen Consumption; Peroxidase; Thiobarbituric Acid Reactive Substances; Vitamin E | 1998 |
Correlations between cholesterol, vitamin E, and vitamin K1 in serum: paradoxical relationships to established epidemiological risk factors for cardiovascular disease.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Fasting; Humans; Hypercholesterolemia; Infant, Newborn; Male; Risk Factors; Vitamin E; Vitamin K 1 | 1998 |
[Serum lipids and vitamin A, C and E concentrations in an adult population of Caracas City].
Topics: Adult; Ascorbic Acid; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Lipids; Male; Middle Aged; Risk Factors; Triglycerides; Venezuela; Vitamin A; Vitamin E | 1998 |
Cardiovascular pathology possibly associated with ketamine/xylazine anesthesia in Dutch belted rabbits.
Topics: Anesthesia; Anesthetics; Animals; Antibodies, Viral; Cardiovascular Diseases; Coronavirus; Echocardiography; Fibrosis; Ketamine; Myocarditis; Myocardium; Organ Size; Rabbits; Specific Pathogen-Free Organisms; Vitamin E; Xylazine | 1999 |
Antioxidants are useful in preventing cardiovascular disease: a debate. Pro antioxidants.
Topics: Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Humans; Vitamin E | 1999 |
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Topics: Acetylcholine; Antioxidants; Apolipoproteins; beta Carotene; Blood Flow Velocity; Cardiovascular Diseases; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Reference Values; Risk Factors; Vasodilation; Vitamin A; Vitamin E | 1999 |
Is it really time to perform large intervention trials with antioxidant vitamins to prevent cardiovascular disease?
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Vitamin E | 1999 |
Antioxidant vitamins and cardiovascular disease.
Topics: Antioxidants; Cardiovascular Diseases; Humans; Lipoproteins, LDL; Vitamin E; Vitamins | 1999 |
Women and heart disease.
Topics: Cardiovascular Diseases; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Vitamin E | 1999 |
To E or not to E.
Topics: Arteriosclerosis; Cardiovascular Diseases; Humans; Lipid Peroxidation; Risk; Vitamin E | 1999 |
Health beat. Vitamin E: E for exaggerated?
Topics: Cardiovascular Diseases; Humans; Vitamin E | 2000 |
Effect of menopause on low-density lipoprotein oxidation: is oestrogen an important determinant?
Topics: Adult; Antioxidants; Cardiovascular Diseases; Case-Control Studies; Estradiol; Female; Humans; Linear Models; Lipoproteins, LDL; Menopause; Middle Aged; Oxidation-Reduction; Vitamin E; Women's Health | 2000 |
Vitamin E shows no benefit in heart disease.
Topics: Cardiovascular Diseases; Female; Humans; Male; Vitamin E | 2000 |
Study weakens case for vitamin E supplementation.
Topics: Cardiovascular Diseases; Humans; Vitamin E | 2000 |
[Antioxidant vitamins in the prevention of cardiovascular diseases. 2nd part: results of clinical trials].
Topics: Ascorbic Acid; Cardiovascular Diseases; Evidence-Based Medicine; Humans; Preventive Medicine; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin A; Vitamin E | 2000 |
[Clinical study of the month. The HOPE study, a two-by-two factorial clinical trial with contrasted results].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Complications; Humans; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vitamin E | 2000 |
Vitamin E does not prevent cardiovascular events in high-risk patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Dietary Supplements; Humans; Middle Aged; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Vitamin E | 2000 |
[Antioxidant vitamins in the prevention of cardiovascular diseases. First part: epidemiologic studies].
Topics: Ascorbic Acid; Cardiovascular Diseases; Case-Control Studies; Cultural Characteristics; Epidemiologic Studies; Humans; Vitamin A; Vitamin E | 2000 |
Vitamin E supplementation and cardiovascular events in high-risk patients.
Topics: Cardiovascular Diseases; Humans; Vitamin E | 2000 |
Measurement of lipid-soluble vitamins--further adjustment needed?
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Humans; Reference Values; Solubility; Vitamin E; Vitamin K | 2000 |
Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention.
Topics: Animals; Anthocyanins; Antioxidants; Apoptosis; Ascorbic Acid; beta Carotene; Biological Availability; Cardiovascular Diseases; Dose-Response Relationship, Drug; Flow Cytometry; Free Radical Scavengers; Free Radicals; Humans; Keratinocytes; Kidney Diseases; Liver Diseases; Neoplasms; Plant Extracts; Proanthocyanidins; Seeds; Vitamin E | 2000 |
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
Topics: Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Renal Dialysis; Risk Factors; Sulfhydryl Compounds; Uric Acid; Vitamin E | 2000 |
Weighing the evidence for vitamin supplementation and CVD prevention.
Topics: Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Female; Humans; Male; Sensitivity and Specificity; Vitamin B Complex; Vitamin E; Vitamins | 2000 |
What role can diet play in the increased risk of cardiovascular disease in women aged 40 years and over?
Topics: Adult; Cardiovascular Diseases; Diet; Dietary Supplements; Female; Humans; Vitamin E; Women's Health | 2000 |
Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study.
Topics: Cardiovascular Diseases; Evaluation Studies as Topic; Humans; Public Health; Ramipril; Research; Treatment Outcome; Vitamin E | 2001 |
Therapy and clinical trials.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Lipid Peroxidation; Vitamin E | 2001 |
Dietary intake as a cardiovascular risk factor in Costa Rican adolescents.
Topics: Adolescent; Adult; Analysis of Variance; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol, Dietary; Costa Rica; Diet; Dietary Fats; Dietary Fiber; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Male; Pyridoxine; Risk Factors; Sodium; Vitamin E | 2001 |
Vitamin E and cardiovascular disease.
Topics: Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Humans; Thrombosis; Vitamin E | 2001 |
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients.
Topics: Aged; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Vitamin E | 2001 |
Antioxidant strategy for cardiovascular diseases.
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Cause of Death; Data Interpretation, Statistical; Humans; Randomized Controlled Trials as Topic; Survival Rate; Vitamin E | 2001 |
Antioxidant strategy for cardiovascular disease.
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Follow-Up Studies; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vitamin E | 2001 |
[The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice].
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 2001 |
[Honest nutritional counseling concerning vitamin E II].
Topics: Antioxidants; Cardiovascular Diseases; Humans; Meta-Analysis as Topic; Practice Guidelines as Topic; Vitamin E | 2001 |
Vitamin E supplementation.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Drug Synergism; Humans; Vitamin E | 2001 |
Vitamin E supplementation.
Topics: Antioxidants; Cardiovascular Diseases; Drug Synergism; Humans; Kidney Failure, Chronic; Vitamin E | 2001 |
Vitamin E supplementation.
Topics: Cardiovascular Diseases; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Lipid Peroxidation; Oxidative Stress; Renal Dialysis; Vitamin E | 2001 |
Are ACE inhibitors a "magic bullet" against oxidative stress?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular Diseases; Humans; Lipoproteins, LDL; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Vasoconstriction; Vitamin E | 2001 |
Clinical trials with vitamin E in cardiovascular disease: are they meaningful?
Topics: Antioxidants; Biological Availability; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Intestinal Absorption; Oxidation-Reduction; Research Design; Treatment Outcome; Vitamin E | 2001 |
Oxidant stress as a marker for cardiovascular events: Ox marks the spot.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Endothelium, Vascular; Forearm; Humans; Nitric Oxide; Oxidative Stress; Predictive Value of Tests; Regional Blood Flow; Treatment Outcome; Vasodilation; Vitamin E | 2001 |
[Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project].
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome; Vitamin E | 2001 |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E | 2002 |
What vitamins should I be taking?
Topics: Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Vitamin E | 2002 |
Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality.
Topics: Adult; Aged; Ascorbic Acid; Cardiovascular Diseases; Cohort Studies; Confidence Intervals; Dietary Supplements; Humans; Male; Middle Aged; Physicians; Prospective Studies; Risk; Surveys and Questionnaires; Treatment Outcome; United States; Vitamin E; Vitamins | 2002 |
Oxidative stress during ex vivo hemodialysis of blood is decreased by a novel hemolipodialysis procedure utilizing antioxidants.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Lipid Peroxidation; Lipoproteins, LDL; Oxidative Stress; Renal Dialysis; Thiobarbituric Acid Reactive Substances; Vitamin E | 2002 |
[The behaviour of alpha-tocopherol in acute and chronic vascular disorders (author's transl)].
Topics: Adult; Aged; Animals; Cardiovascular Diseases; Cholesterol; Humans; Lipid Peroxides; Middle Aged; Rats; Vitamin E | 1979 |
[On the therapeutic use of vitamin E in clinical medicine: motivations and prospects].
Topics: Aging; Cardiovascular Diseases; Endocrine System Diseases; Hematologic Diseases; Humans; Metabolic Diseases; Respiratory Tract Diseases; Vitamin E | 1977 |
Vitamin E status of Chinese population in Taiwan.
Topics: Adolescent; Adult; Age Factors; Aged; Cardiovascular Diseases; Child; China; Cholesterol; Erythrocytes; Female; Hemolysis; Humans; Hydrogen Peroxide; Infant, Newborn; Male; Middle Aged; Nutrition Surveys; Reference Values; Taiwan; Vitamin E; Vitamin E Deficiency | 1977 |
Antioxidant status (selenium, vitamins A and E) and aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Antioxidants; Cardiovascular Diseases; Diet; Female; Food, Fortified; Humans; Male; Middle Aged; Neoplasms; Reference Values; Selenium; Sex Characteristics; Vitamin A; Vitamin E | 1992 |
Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke respectively: 12-year follow-up of the Prospective Basel Study.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Carotenoids; Cerebrovascular Disorders; Cholesterol; Female; Follow-Up Studies; Free Radicals; Humans; Male; Myocardial Ischemia; Neoplasms; Prospective Studies; Risk Factors; Switzerland; Vitamin A; Vitamin E; Vitamins | 1992 |
Forum offers hints of future therapy, prevention programs for combating cardiovascular problems.
Topics: Animals; Arteriosclerosis; Aspirin; Cardiomegaly; Cardiovascular Diseases; Female; Genetic Therapy; Heart-Assist Devices; Humans; Smoking; Vitamin E | 1992 |
Myocardial vitamin E (alpha-tocopherol) contents of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Vitamin E | 1988 |
Eating habits of the dentist and his wife: daily consumption of vitamin E.
Topics: Cardiovascular Diseases; Computers; Dentists; Dose-Response Relationship, Drug; Family; Feeding Behavior; Female; Health Education; Humans; Male; Nutrition Surveys; Nutritional Requirements; Surveys and Questionnaires; Vitamin E | 1974 |
Predictive medicine. XIV. Results.
Topics: Adult; Age Factors; Aging; Cardiovascular Diseases; Diet; Electrocardiography; Female; Health Education; Humans; Male; Middle Aged; Multiphasic Screening; Nutrition Surveys; Physical Exertion; Prognosis; Sex Factors; Vitamin E | 1972 |
Twenty-four years using alpha-tocopherol in degenerative cardiovascular disease.
Topics: Angina Pectoris; Arteriosclerosis; Cardiac Glycosides; Cardiovascular Diseases; Coronary Disease; Drug Synergism; Heart Failure; Humans; Myocardial Infarction; Thromboangiitis Obliterans; Thrombophlebitis; Vitamin E | 1970 |
Interrelation of serum lipoprotein and tocopherol levels.
Topics: Arteries; Blood Protein Electrophoresis; Cardiovascular Diseases; Cholesterol; Chromatography, Thin Layer; Female; Hepatitis; Humans; Hyperthyroidism; Hypothyroidism; Lipoproteins; Liver Cirrhosis; Malabsorption Syndromes; Pregnancy; Vitamin E | 1969 |
[Geriatric treatment with A 66].
Topics: Aged; Animals; Cardiovascular Diseases; Dementia; Dogs; Geriatrics; Humans; Metabolic Diseases; Middle Aged; Plant Extracts; Plants, Medicinal; Pulmonary Emphysema; Rutin; Sympatholytics; Vitamin A; Vitamin E; Vitamins | 1969 |